%PDF-1.3
%‚„œ”
1 0 obj
<<
/Type/ExtGState
/OPM 1
>>
endobj
2 0 obj
<<
/SM 0.01
/Type/ExtGState
/FL 1
>>
endobj
3 0 obj
<<
/Type/ExtGState
/OP true
>>
endobj
4 0 obj
<<
/Type/ExtGState
/OP false
>>
endobj
5 0 obj
<<
/Length 8546
>>
stream
/GS0 gs
q
0 0.654 498 691 re
W n
1 g
0 691.654 0 0 re
f
Q
/GS1 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 75.1181 451.535 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0.085 Tw
[(Se)15(g\234n la OMS,)-331(a ni)25(v)15(el mundial,)-330(la def)19(i-)]TJ
-1.13386 -1.1 TD
0.016 Tw
[(ciencia de yodo \(D)55(Y\) es la causa pre)25(v)14(enible)]TJ
T*
0.359 Tw
(m\207s impor)Tj
4.56261 0 TD
(tante de da\226o cer)Tj
7.79222 0 TD
0 Tc
(e)Tj
0.43885 0 TD
-0.005 Tc
0 Tw
(br)Tj
0.82277 0 TD
0.359 Tw
(al. Hasta)Tj
-13.61645 -1.10001 TD
0.025 Tw
[(hace poco m\207s de v)15(einte a\226os,)-270(las alteracio-)]TJ
0 -1.1 TD
0.271 Tw
[(nes m\207s cl\207sicamente asociadas a la D)55(Y)]TJ
T*
0 Tw
(er)Tj
0.76662 0 TD
0.195 Tw
(an el bocio,)Tj
5.40604 0 TD
(como la m\207s visib)Tj
7.74738 0 TD
(le y fr)Tj
2.74143 0 TD
0 Tc
(e)Tj
0.43885 0 TD
(-)Tj
-17.10032 -1.10002 TD
-0.005 Tc
0.345 Tw
[(cuente,)-591(y el cretinismo que,)-590(a\234n siendo)]TJ
0 -1.1 TD
0.171 Tw
[(much\222simo menos pre)25(v)25(alente,)-417(es la altera-)]TJ
T*
-0.011 Tw
[(ci\227n m\207s gra)20(v)15(e. Posteriormente se les suma-)]TJ
T*
-0.028 Tw
(ron toda una serie de trastornos entre los que)Tj
T*
0.085 Tw
[(destacan el aumento de abortos,)-330(prema)-1(turi-)]TJ
T*
0 Tw
(dad)Tj
1.42886 0 TD
0 Tc
(,)Tj
0.45999 0 TD
-0.005 Tc
-0.03 Tw
[(la presencia de d\216f)19(icits psicomotores de)]TJ
-1.88885 -1.10001 TD
0.071 Tw
(distinto g)Tj
3.77151 0 TD
0 Tc
(r)Tj
0.32777 0 TD
-0.005 Tc
0 Tw
(ado,)Tj
1.9901 0 TD
0.071 Tw
[(el hipotiroidismo,)-317(el hiperti-)]TJ
-6.08938 -1.10001 TD
0.025 Tw
[(roidismo subcl\222nico,)-270(la presencia de d\216f)20(icits)]TJ
0 -1.1 TD
0 Tw
(auditi)Tj
2.22246 0 TD
0 Tc
(v)Tj
0.47523 0 TD
-0.005 Tc
0.086 Tw
(os y tambi\216n se incor)Tj
8.73621 0 TD
(por\227 un ma)Tj
4.67639 0 TD
0 Tc
(y)Tj
0.49501 0 TD
-0.005 Tc
0 Tw
(or)Tj
-16.6053 -1.10002 TD
0.009 Tc
0.361 Tw
[(r)1(iesg)-1(o por accidentes nucl)1(e)1(a)1(r)1(e)1(s)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 201.9569 289.8351 Tm
0 Tr
0 0 0 1 k
0 Tc
(1)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 205.5177 286.535 Tm
0 Tr
0 0 0 1 k
0.0087 Tc
(.)Tj
0.86085 0 Td
0.009 Tc
0 Tw
[(T)80(odas)]TJ
-15.03467 -1.1 TD
-0.005 Tc
0.105 Tw
[(estas alteraciones no s\227lo se dan en pobla)-1(-)]TJ
T*
0.076 Tw
[(ciones con una gra)20(v)15(e D)55(Y sino que tambi\216n)]TJ
T*
0.239 Tw
[(el riesgo e)14(xiste entre poblaciones con un)]TJ
T*
0.025 Tw
[(d\216f)20(icit le)24(v)15(e o moderado)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 157.4622 245.8351 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 160.9272 242.535 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
-4.96813 -3.29996 TD
0.025 Tw
(LA PREVENCI\356N)Tj
-1.17559 -1.1 TD
-0.0001 Tc
(DE)Tj
1.60772 0 Td
0 Tc
0.007 Tw
[(LOS TRAST)17(ORNOS)]TJ
-3.03538 -1.1 TD
0.025 Tw
[(POR DEFICIENCIA DE )90(Y)30(ODO)]TJ
-1.00953 -2.20013 TD
-0.005 Tc
-0.005 Tw
(Los r)Tj
2.0523 0.00001 TD
0 Tw
(equer)Tj
2.19548 0.00001 TD
-0.005 Tw
(imientos de y)Tj
5.31251 0.00001 TD
(odo est\207n alrede-)Tj
-10.69415 -1.10002 TD
-0.009 Tw
[(dor de los 90 \265g al d\222a de los 0 a 6 a\226os,)-236(120)]TJ
0 -1.10001 TD
0.062 Tw
[(\265g de los 6 a los 12 a\226os,)-307(y a partir de esta)]TJ
19.70079 30.67979 TD
0.028 Tw
(edad 150 \265g)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 309.6666 453.632 Tm
0 Tr
0 0 0 1 k
0 Tc
(3)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 313.1316 450.332 Tm
0 Tr
0 0 0 1 k
-0.0051 Tc
(.)Tj
0.51744 0 Td
-0.005 Tc
0.028 Tw
(Durante la gestaci\227n y la lac-)Tj
-5.75186 -1.1 TD
0.145 Tw
(tancia las necesidades se incrementan m\207s)Tj
T*
0.057 Tw
[(del 50% lle)15(g)5(ando hasta los 250 \265g)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 399.5452 431.632 Tm
0 Tr
0 0 0 1 k
0 Tc
(4)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 403.0102 428.332 Tm
0 Tr
0 0 0 1 k
-0.0051 Tc
(.)Tj
0.54668 0 Td
-0.005 Tc
0.057 Tw
(El c\207l-)Tj
-14.76897 -1.1 TD
0.181 Tw
(culo de estos requerimientos se ha funda-)Tj
T*
0.113 Tw
[(mentado en di)25(v)15(er)-1(sos estudios que han per-)]TJ
T*
0.33 Tw
(mitido conocer el comportamiento de la)Tj
T*
0 Tw
(gl\207ndula ante la ingesta de distintas cantida-)Tj
T*
0.032 Tw
(des y)Tj
2.09013 0 TD
0 Tw
(odo)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 296.5388 376.632 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(5,6)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 305.1839 373.332 Tm
0 Tr
0 0 0 1 k
0 Tc
(,)Tj
0.52236 0 TD
-0.005 Tc
0.032 Tw
(entendiendo los r)Tj
6.86648 0 TD
0 Tw
(equerimientos)Tj
-11.82849 -1.10001 TD
0.275 Tw
(aconsejados como la ingesta m\222nima por)Tj
0 -1.1 TD
-0.012 Tw
[(debajo de la cual podr\222a entorpecer)-1(se el nor-)]TJ
T*
0.254 Tw
(mal funcionamiento de la tir)Tj
12.20435 0 TD
(oides con el)Tj
-12.20435 -1.1 TD
0.125 Tw
(consiguiente aumento del riesgo de que se)Tj
T*
0 Tw
(pr)Tj
0.82277 0 TD
0.025 Tw
(oduzcan alter)Tj
5.3177 0 TD
0 Tw
(aciones.)Tj
-5.00661 -2.20014 TD
0 Tc
0.036 Tw
[(Existen difer)-1(ent)1(e)-1(s m\216todos p)1(a)-1(ra g)5(aranti-)]TJ
-1.13386 -1.1 TD
0.147 Tw
(zar un a)Tj
3.45741 0 TD
0 Tw
(por)Tj
1.33276 0 TD
0.147 Tw
(te adecuado de y)Tj
7.13057 0 TD
(odo ca)Tj
2.78424 0 TD
(paz de)Tj
-14.70498 -1.10002 TD
0.033 Tw
[(corre)15(gir una D)55(Y)129(,)-283(o bien pre)25(v)15(enir)-1(la,)-283(que v)25(an)]TJ
0 -1.1 TD
0.155 Tw
(desde la administraci\227n de aceite yodado,)Tj
T*
0.079 Tw
[(yodaci\227n del agua de consumo,)-329(de la hari-)]TJ
T*
-0.028 Tw
[(na,)-222(de la leche o de la sal. Cada opci\227n tiene)]TJ
T*
0.155 Tw
(sus par)Tj
2.95903 0 TD
[(ticularidades,)-405(como por ejemplo el)]TJ
-2.95903 -1.1 TD
0.075 Tw
(aceite y)Tj
3.15586 0 TD
(odado que se ha utilizado en situa)Tj
13.94444 0 TD
(-)Tj
-17.1003 -1.10001 TD
0.018 Tw
[(ciones de emer)18(gencia donde la gra)20(v)15(edad de)]TJ
0 -1.1 TD
0.099 Tw
(la endemia no per)Tj
7.43233 0.00001 TD
(mit\222a esper)Tj
4.51349 0.00001 TD
(ar que la tec-)Tj
-11.94582 -1.10001 TD
0.01 Tw
(nolog\222a pudiera yodar otros alimentos. Este)Tj
0 -1.1 TD
0.013 Tw
[(fue el caso de pa\222ses como Nue)25(v)25(a Guinea o)]TJ
T*
0 Tw
(Zaire)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 281.8787 167.6307 Tm
0 Tr
0 0 0 1 k
0 Tc
(7)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 289.5507 164.3307 Tm
0 Tr
0 0 0 1 k
0 Tc
0.167 Tw
[(donde la pre)25(v)25(alencia de cretinismo)]TJ
-2.87633 -1.1 TD
0 Tw
(er)Tj
0.77661 0.00001 TD
-0.0002 Tc
(a)Tj
0.75511 0 Td
0 Tc
0.061 Tw
[(muy ele)25(v)25(ado por lo que el aceite y)-1(oda-)]TJ
-1.53172 -1.1 TD
0.1 Tw
[(do se administr\227 como una v)25(acuna. Desde)]TJ
T*
-0.017 Tw
[(hace a\226os la OMS y otros or)18(g)5(anismos inter)-1(-)]TJ
T*
0.284 Tw
[(nacionales,)-534(como UNICEF)80(,)-533(han a)-1(bog)5(ado)]TJ
T*
0.046 Tw
(por la y)Tj
3.14623 0.00001 TD
(odaci\227n de la sal por ser el alimen)Tj
13.95408 0.00001 TD
(-)Tj
-17.10031 -1.10002 TD
0.027 Tw
(to de consumo m\207s generalizado en todo el)Tj
0 -1.1 TD
0.163 Tw
[(mundo. )55(Adem\207s def)20(ienden no \234nicamente)]TJ
T*
0.104 Tw
[(la yodaci\227n de la sal de mesa,)-355(sino que la)]TJ
ET
0 J 0 j 10 M []0 d 1 w 
0 0 0 1 K
63.78 624.598 m
435.118 624.598 l
S
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
6 0 0 6 63.7795 627.9326 Tm
0 Tr
0 0 0 1 k
-0.0002 Tc
(R)Tj
0.66683 -0.00001 TD
0 Tc
0.025 Tw
[(e)25(v Esp Salud P\234blica 2008; 82:)-275(371-377)]TJ
50.75232 0 Td
[(N.\241)-275(4 - Julio-Agosto 2008)]TJ
ET
63.78 589.607 87.874 19.842 re
f
Q
/GS3 gs
q
BT
/F1 1 Tf
11 0 0 11 76.3413 594.8139 Tm
0 Tr
0 0 0 0 k
0 Tc
0 Tw
[(EDIT)18(ORIAL)]TJ
ET
Q
/GS2 gs
q
BT
/F1 1 Tf
10 0 0 10 79.4443 542.932 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(PREVENCI\356N )55(Y CONTR)30(OL DE LA DEFICIENCIA DE )54(Y)35(ODO EN ESP)74(A\204A)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F1 1 Tf
9 0 0 9 63.7795 507.631 Tm
0 Tr
0 0 0 1 k
0 Tc
-0.02 Tw
[(Llu\222s V)37(ila )-45((1,2))]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
8 0 0 8 63.7795 492.9617 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[((1))-500(Servicio de Endocr)-1(inolog\222a y Nutrici\227n. Hospital Dos de Maig. Barcelona.)]TJ
ET
0 J 0 j 10 M []0 d 1 w 
0 0 0 1 K
63.78 472.123 m
435.118 472.123 l
S
BT
/F0 1 Tf
8 0 0 8 63.7795 483.9617 Tm
-0.01 Tc
-0.037 Tw
[((2))-490(Gr)-1(upo de estudio de los )18(T)35(rastornos por Def)20(iciencia de )89(Y)110(odo de la Sociedad Espa\226ola de Endocrinolog\222a y Nutrici\227n.)]TJ
ET
0.5 w 
63.78 129.75 m
117.142 129.75 l
S
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7.5 0 0 7.5 63.7795 118.1618 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(Correspondencia:)Tj
0 -1.0667 TD
-0.025 Tw
[(Llu\222s V)60(ila)]TJ
T*
0 Tw
(Ser)Tj
1.3325 0 TD
0.025 Tw
(vicio de Endocrinolog\222a y Nutrici\227n)Tj
-1.3325 -1.0667 TD
(Hospital Dos de Maig)Tj
T*
0 Tw
(Barcelona)Tj
T*
[(lvila@acmcb)40(.es)]TJ
ET
Q

endstream
endobj
6 0 obj
<<
/Length 12607
>>
stream
/GS0 gs
q
0 0.654 498 691 re
W n
1 g
0 691.654 0 0 re
f
Q
/GS1 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 63.7795 608.1288 Tm
0 Tr
0 0 0 1 k
0 Tc
0.168 Tw
[(yodaci\227n sea uni)25(v)15(er)-1(sal,)-418(es decir que tam-)]TJ
0 -1.10316 TD
0.098 Tw
(bi\216n sea yodada la sal de consumo animal)Tj
T*
-0.016 Tw
(as\222 como la que se utilice en la industria ali-)Tj
0 -1.10317 TD
0.003 Tc
0 Tw
(mentaria)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 99.0322 578.334 Tm
0 Tr
0 0 0 1 k
0 Tc
(8)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 102.5562 575.0339 Tm
0 Tr
0 0 0 1 k
0.0034 Tc
(.)Tj
0.87828 0 Td
0.003 Tc
0.372 Tw
[(Los pa\222ses,)-625(como USA,)-625(que)]TJ
-4.75595 -1.10316 TD
0 Tc
0.131 Tw
[(desde hace muchos a\226os han se)15(guido esta)]TJ
0 -1.10317 TD
0.013 Tw
(recomendaci\227n han erradicado por comple-)Tj
T*
0.234 Tw
[(to los trastornos por def)19(iciencia de yodo)]TJ
0 -1.10316 TD
0.004 Tc
0.371 Tw
[(\(TD)55(Y\). Los ele)24(v)25(ados requerimientos de)]TJ
0 -1.10317 TD
0 Tc
0.129 Tw
(yodo durante la gestaci\227n hace dif\222cil que)Tj
T*
0.009 Tw
(se logre alcanzar una adecuada ingesta s\227lo)Tj
0 -1.10316 TD
0.194 Tw
(con la sal yodada de mesa por lo que la)Tj
T*
0.06 Tw
(OMS aconseja en esta situaci\227n suplemen-)Tj
0 -1.10317 TD
0.025 Tw
(tar con yoduro pot\207sico.)Tj
1.90694 -3.30313 TD
[(LA PREVENCI\356N EN ESP)92(A\204A)]TJ
-0.77308 -2.20329 TD
0.02 Tc
0.374 Tw
[(Cl\207sicamente,)-644(una gran parte de la)]TJ
-1.13386 -1.10316 TD
0 Tc
0 Tw
(pob)Tj
1.5 0 TD
0.079 Tw
(laci\227n en Espa\226a,)Tj
7.51039 0 TD
(al igual que en otr)Tj
7.53378 0 TD
0 Tw
(os)Tj
-16.54417 -1.10317 TD
(m)Tj
0.77783 0 TD
(uc)Tj
0.94385 0 TD
0.255 Tw
(hos pa\222ses de Eur)Tj
7.73348 0 TD
0 Tw
(opa,)Tj
2.19842 0 TD
0.255 Tw
(ha pr)Tj
2.2812 0 TD
0 Tw
(esentado)Tj
-13.93478 -1.10319 TD
0.031 Tw
[(una baja nutrici\227n en yodo. )55(A pesar de esta)]TJ
0 -1.10316 TD
(e)Tj
0.41895 0 TD
0.052 Tw
(videncia hist\227r)Tj
5.96607 0 TD
0 Tw
(ica)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 139.285 379.8585 Tm
0 Tr
0 0 0 1 k
0 Tc
(9)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 142.785 376.5585 Tm
0 Tr
0 0 0 1 k
0 Tc
(,)Tj
0.55153 0 TD
0.052 Tw
(no fue hasta 1983 que)Tj
-8.45208 -1.10317 TD
0.016 Tc
0.359 Tw
(se public\227 el Real Decreto 1424/1983)Tj
0 -1.10316 TD
0 Tc
0.011 Tw
[((BOE n\234m 130/193) que aprobaba la r)-1(e)16(gla)-1(-)]TJ
0 -1.10317 TD
0.166 Tw
(mentaci\227n t\216cnico-sanitaria para la obten-)Tj
0 -1.10316 TD
0 Tw
(ci\227n,)Tj
2.50118 0 TD
(cir)Tj
1.05444 0 TD
0.279 Tw
[(culaci\227n y v)15(enta de sal yodada.)]TJ
-3.55562 -1.10317 TD
0.072 Tw
(Este decr)Tj
3.76372 0 TD
(eto a)Tj
1.98734 0 TD
0 Tw
(par)Tj
1.27662 0 TD
0.072 Tw
(eci\227 setenta a\226os despu\216s)Tj
-7.02768 -1.10318 TD
0.055 Tw
(que la yodaci\227n de la sal se hubiera inicia-)Tj
0 -1.10316 TD
0.094 Tw
[(do como m\216todo pre)25(v)15(enti)25(v)19(o en Suiza y en)]TJ
T*
0.003 Tw
(Estados Unidos)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 126.2994 291.6055 Tm
0 Tr
0 0 0 1 k
0 Tc
(10)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 133.2994 288.3055 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(.)Tj
0.50282 0 Td
0 Tc
0.003 Tw
(No obstante la condici\227n)Tj
-7.45481 -1.10317 TD
-0.002 Tw
[(de consumo v)20(oluntario con la que se imple-)]TJ
0 -1.10316 TD
0.143 Tw
[(ment\227 este decreto,)-393(a dif)-1(erencia de pa\222ses)]TJ
T*
0.016 Tw
[(como )55(Ar)17(gentina,)-265(Estados Unidos u otros de)]TJ
0 -1.10317 TD
0 Tw
(Eur)Tj
1.44361 0 TD
(opa,)Tj
2.05541 0 TD
(ob)Tj
1 0 TD
(lig)Tj
1.05078 0 TD
-0.0001 Tc
(a)Tj
0.80535 0 Td
(a)Tj
0.80535 0 Td
0 Tc
0.112 Tw
(plantear campa\226as per)Tj
9.16198 0 TD
0 Tw
(i\227-)Tj
-16.32247 -1.10318 TD
-0.005 Tw
(dicas de Salud P\234blica para fomentar el uso)Tj
0 -1.10316 TD
-0.022 Tw
[(de la sal yodada y as\222 g)5(ar)-1(antizar no s\227lo que)]TJ
0 -1.10317 TD
-0.0001 Tc
(la)Tj
1.19915 0 Td
0 Tc
0 Tw
(pob)Tj
1.49987 0 TD
0.227 Tw
(laci\227n alcance una adecuada nutri-)Tj
-2.69902 -1.10316 TD
0.122 Tw
(ci\227n de este elemento sino que adem\207s se)Tj
T*
0.017 Tw
[(manteng)5(a en el tiempo. De los 40 pa\222ses de)]TJ
0 -1.10318 TD
0.083 Tw
(Europa que la OMS contabiliza en su \234lti-)Tj
0 -1.10315 TD
0.195 Tw
(mo inf)Tj
2.83335 0.00001 TD
0 Tw
(or)Tj
0.83276 0.00001 TD
(me)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 112.6574 170.2575 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 116.1574 166.9576 Tm
0 Tr
0 0 0 1 k
0 Tc
(,)Tj
0.69491 0.00001 TD
0.195 Tw
(s\227lo 13 tienen un consumo)Tj
-5.9327 -1.10317 TD
0.083 Tw
[(oblig)5(atorio de sal yodada. De \216stos,)-334(9 pre-)]TJ
0 -1.10316 TD
0.059 Tw
(sentan una adecuada nutrici\227n en yodo y 3)Tj
0 -1.10317 TD
(m)Tj
0.77783 0.00001 TD
0 Tw
(uestr)Tj
1.94336 0.00001 TD
0.173 Tw
(an a\234n una def)Tj
6.35604 0.00001 TD
[(iciencia le)25(v)15(e coinci-)]TJ
-9.07723 -1.10318 TD
0.083 Tw
[(diendo,)-333(en parte,)-333(con los pa\222ses en los que)]TJ
T*
-0.009 Tw
[(la implantaci\227n de la oblig)5(atoriedad ha sido)]TJ
T*
0.012 Tw
(m\207s r)Tj
2.2052 0 TD
0 Tw
(eciente)Tj
2.8311 0 TD
-0.0001 Tc
(.)Tj
0.5117 0 Td
0 Tc
0.012 Tw
(De los 16 pa\222ses en los que el)Tj
-5.548 -1.1032 TD
0.248 Tw
[(consumo de sal yodada es v)20(oluntario,)-498(la)]TJ
T*
0.03 Tw
[(OMS s\227lo clasif)19(ica a la mitad entre los que)]TJ
19.70079 52.94243 TD
0.235 Tw
(est\207n con una \227ptima nutrici\227n de yodo,)Tj
0 -1.10309 TD
-0.037 Tw
[(coincidiendo,)-214(en su mayor\222a,)-213(con los que las)]TJ
0 -1.1031 TD
0.085 Tw
[(respecti)25(v)25(as le)15(gislaciones sobre la y)-1(odaci\227n)]TJ
T*
0.001 Tw
[(de la sal son m\207s antiguas,)-251(es decir)40(,)-251(que tie-)]TJ
0 -1.10309 TD
0.003 Tw
[(nen m\207s de 20 a\226os,)-253(destacando la de Suiza)]TJ
T*
0.011 Tw
(que data de 1922 o la de Suecia que se pro-)Tj
0 -1.1031 TD
0.025 Tw
(mulg\227 en 1936.)Tj
1.13386 -2.20321 TD
-0.005 Tc
0.176 Tw
(En este \234ltimo informe de la OMS del)Tj
-1.13386 -1.1031 TD
-0.018 Tw
(a\226o 2007)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 297.1433 512.1803 Tm
0 Tr
0 0 0 1 k
0 Tc
(2)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 302.8755 508.8802 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
-0.018 Tw
(Espa\226a aparece como un pa\222s con)Tj
-4.20881 -1.10309 TD
0.316 Tw
(una \227ptima nutrici\227n de yodo al mismo)Tj
0 -1.1031 TD
0.022 Tw
[(ni)25(v)15(el que Suecia,)-268(Fin)1(l)-1(an)1(dia,)-268(Suiza o )55(Alema-)]TJ
0 -1.10309 TD
0.217 Tw
[(nia y por delante de Dinamarca,)-462(B\216lg)-1(ica,)]TJ
T*
-0.006 Tw
(Francia o Italia. La OMS se basa en algunos)Tj
T*
0.01 Tw
(de los estudios publicados en los \234ltimos 10)Tj
T*
0.372 Tw
[(a\226os,)-617(realizados en Galicia)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 377.7654 445.9948 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(11)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 384.6954 442.6948 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
[(,)-562(Asturias)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 425.6881 445.9948 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(12)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 432.6181 442.6948 Tm
0 Tr
0 0 0 1 k
0 Tc
(,)Tj
-17.18307 -1.1031 TD
-0.005 Tc
0 Tw
(Pir)Tj
1.15151 0 TD
0.027 Tw
(ineos y L\216r)Tj
4.4968 0 TD
0 Tw
(ida)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 329.3374 434.9639 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(13)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 336.2674 431.6638 Tm
0 Tr
0 0 0 1 k
0 Tc
(,)Tj
0.51686 0 TD
(J)Tj
0.38392 0 TD
-0.005 Tc
0 Tw
(a\216n)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 359.0023 434.9639 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(14)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 368.6509 431.6638 Tm
0 Tr
0 0 0 1 k
-0.0051 Tc
(y)Tj
0.7667 0 Td
-0.005 Tc
0 Tw
(C\207diz)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 399.3949 434.9639 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(15)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 406.3249 431.6638 Tm
0 Tr
0 0 0 1 k
0 Tc
(,)Tj
0.51687 0 TD
-0.005 Tc
0.027 Tw
(en los)Tj
-15.07062 -1.10309 TD
0.16 Tw
[(que realmente se observ)25(aba un importante)]TJ
T*
0.002 Tw
(cambio de la yoduria respecto a los estudios)Tj
T*
0.221 Tw
[(pre)25(vios alcanzando medianas superior)-1(es a)]TJ
T*
0.022 Tw
(los 100 )Tj
3.17075 0 TD
[(\265g/L,)-267(punto de corte por encima del)]TJ
-3.17075 -1.1031 TD
-0.014 Tw
(cual la OMS def)Tj
6.44336 0 TD
(ine a una pob)Tj
5.25194 0 TD
(laci\227n con una)Tj
-11.6953 -1.10309 TD
0.011 Tw
(adecuada nutrici\227n de yodo)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 370.0634 368.7784 Tm
0 Tr
0 0 0 1 k
0 Tc
(3)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 373.5284 365.4784 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
(.)Tj
0.48363 0 Td
0.011 Tw
[(T)80(ambi\216n otros)]TJ
-11.75773 -1.1031 TD
0.155 Tw
(estudios pub)Tj
5.12283 0 TD
[(licados,)-401(en esta misma \216poca,)]TJ
-5.12283 -1.10309 TD
-0.032 Tw
(en Catalu\226a)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 307.3935 346.7165 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(16,17)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 322.9686 343.4165 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
[(,)-163(V)111(alencia)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 361.0675 346.7165 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(18)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 370.1229 343.4165 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
(y)Tj
0.6526 0 Td
0 Tw
(Alicante)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 410.1188 346.7165 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(19)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 419.1742 343.4165 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(pre-)Tj
-15.83868 -1.10309 TD
0.298 Tw
[(sentan medianas de yoduria superior)-1(es a)]TJ
T*
0 Tw
(100 )Tj
1.97204 0 TD
0 Tc
<B5>Tj
0.49501 0 TD
-0.005 Tc
0.242 Tw
(g/L. El cambio obser)Tj
9.01238 0 TD
0 Tc
(v)Tj
0.4701 0 TD
-0.005 Tc
(ado en todos)Tj
-11.94953 -1.1031 TD
0.31 Tw
[(estos estudios,)-555(muy probablemente,)-555(debe)]TJ
0 -1.10309 TD
0 Tc
(r)Tj
0.32777 0 TD
-0.005 Tc
0 Tw
(elacionar)Tj
3.61884 0 TD
0.165 Tw
(se con un aumento del consumo)Tj
-3.94661 -1.1031 TD
-0.01 Tw
(de sal y)Tj
2.99386 0 TD
(odada. Este hec)Tj
6.15126 0 TD
(ho es contundente en)Tj
-9.14512 -1.10311 TD
-0.024 Tw
[(los estudios de )50(V)111(alencia)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 354.1793 280.5311 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(18)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 363.3222 277.231 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
(y)Tj
0.66135 0 Td
0 Tw
(Asturias)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 402.8563 280.5311 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(12)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 411.9992 277.231 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
-0.024 Tw
(en los)Tj
-15.12118 -1.10309 TD
0 Tw
(que)Tj
1.42886 0 TD
0 Tc
(,)Tj
0.4873 0 TD
-0.005 Tc
-0.003 Tw
[(respecti)25(v)25(amente,)-243(el 73% y el 75% de la)]TJ
-1.91616 -1.1031 TD
0.137 Tw
[(poblaci\227n estudiada af)20(ir)-1(maba consumir sal)]TJ
0 -1.10309 TD
0.118 Tw
[(yodada. )18(T)80(ambi\216n el estudio que se publica)]TJ
T*
0.19 Tw
[(en este n\234mero,)-435(sobr)-1(e la v)25(aloraci\227n de la)]TJ
T*
0 Tw
(tir)Tj
0.87344 0 TD
0.146 Tw
(otropinemia neonatal como indicador de)Tj
-0.87344 -1.10309 TD
0.013 Tw
[(la nutrici\227n de yodo,)-258(v)25(a en sinton\222a con esta)]TJ
0 -1.1031 TD
0.032 Tw
[(f)10(a)20(v)20(or)-1(a)1(ble e)24(v)20(oluci\227n de la yodaci\227n en algu-)]TJ
0 -1.10309 TD
0.025 Tw
(nas zonas de Espa\226a)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 342.4947 192.2837 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(20)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 349.4247 188.9837 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
-7.72987 -2.20321 TD
-0.01 Tc
0.296 Tw
(Sin embar)Tj
4.27013 0.00001 TD
0 Tc
(g)Tj
0.49 0.00001 TD
-0.01 Tc
0 Tw
(o,)Tj
1.26589 0.00001 TD
-0.0101 Tc
(a)Tj
0.96973 0 Td
-0.01 Tc
0.296 Tw
(pesar de estos b)Tj
7.01067 0.00001 TD
0 Tw
(uenos)Tj
-15.14028 -1.10313 TD
0.159 Tw
[(resultados,)-399(debe e)25(vitarse el triunf)9(alismo ya)]TJ
0 -1.10309 TD
0.051 Tw
[(que,)-291(como se dec\222a anteriormente,)-291(el consu-)]TJ
0 -1.1031 TD
0.011 Tw
[(mo v)20(oluntario de sal yodada oblig)4(a a mante-)]TJ
0 -1.10309 TD
0.052 Tw
(ner pr)Tj
2.35117 0.00001 TD
0 Tc
(o)Tj
0.49001 0.00001 TD
-0.01 Tc
[(gramas de salud p\234blica que g)5(aranti-)]TJ
-2.84118 -1.1031 TD
0.198 Tw
[(cen la presencia efecti)25(v)24(a de esta sal en el)]TJ
0 -1.10309 TD
0.208 Tw
[(mercado,)-448(su correcta yodaci\227n y que pro-)]TJ
0 -1.1031 TD
-0.001 Tw
[(mue)25(v)25(an su empleo entre la poblaci\227n. Se)15(g\234n)]TJ
T*
0.281 Tw
(la OMS estos programas son un proceso)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
6 0 0 6 63.7795 647.7751 Tm
0 Tr
0 0 0 1 k
0 Tc
-0.025 Tw
[(Ll. V)60(ila)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
8 0 0 8 63.7795 53.9363 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(372)-27412(Re)25(v Esp Salud P\234blica 2008,)-225(V)128(ol. 82,)-275(N)1<2EA1>-275(4)]TJ
ET
Q

endstream
endobj
7 0 obj
<<
/Length 9961
>>
stream
/GS0 gs
q
0 0.654 498 691 re
W n
1 g
0 691.654 0 0 re
f
Q
/GS1 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 63.7795 608.1288 Tm
0 Tr
0 0 0 1 k
-0.01 Tc
-0.033 Tw
[(continuo y c\222clico,)-207(que adem\207s precisan de la)]TJ
0 -1.1 TD
0.097 Tw
(implicaci\227n no s\227lo de los profesionales de)Tj
T*
0.021 Tw
(la salud sino tambi\216n de los pol\222ticos y de la)Tj
T*
0.341 Tw
(industria salinera. La OMS propone seis)Tj
T*
-0.02 Tw
[(f)10(ases para lle)25(v)25(ar a ca)-1(bo un progr)1(ama destina-)]TJ
-0.0101 Tc
(do)'
1.22398 0 Td
(a)Tj
0.67807 0 Td
-0.01 Tc
0.004 Tw
[(la erradicaci\227n de los )18(TD)55(Y)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 187.9206 556.4288 Tm
0 Tr
0 0 0 1 k
-0.01 Tc
(2)Tj
0.49 0.00001 TD
(1)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 194.7807 553.1288 Tm
0 Tr
0 0 0 1 k
-0.0101 Tc
(.)Tj
0.48404 0 Td
-0.01 Tc
0.004 Tw
[(La f)10(ase 1\273)]TJ
-13.58416 -1.1 TD
0.033 Tw
[(contempla el an\207lisis de la situaci\227n,)-273(la 2\273 la)]TJ
T*
-0.001 Tw
[(difusi\227n de los resultados y de los benef)20(icios)]TJ
0 -1.10001 TD
0.042 Tw
[(de la erradicaci\227n de los )18(TD)55(Y entre los pr)-1(o-)]TJ
0 -1.1 TD
0.147 Tw
[(fesionales de la salud y la poblaci\227n,)-387(la 3\273)]TJ
T*
0.053 Tw
[(f)10(ase es la de planif)20(icaci\227n con equipos mul-)]TJ
T*
0.138 Tw
[(tidisciplinarios de e)15(xpertos y con represen)-1(-)]TJ
T*
0.032 Tw
[(tantes de los Departamentos de Salud P\234bli)-1(-)]TJ
T*
0.03 Tw
[(ca,)-270(la 4\273 la implicaci\227n de los pol\222ticos,)-271(la 5\273)]TJ
T*
-0.012 Tw
(implementaci\227n del pr)Tj
8.76306 0 TD
(ograma \(formaci\227n de)Tj
-8.76306 -1.1 TD
0.344 Tw
[(profesionales,)-585(implicaci\227n de la industria)]TJ
T*
-0.01 Tw
(salinera y realizar campa\226as para al concien-)Tj
T*
0.072 Tw
[(ciaci\227n de la poblaci\227n\) y la 6\273 f)10(ase es para)]TJ
T*
-0.027 Tw
(la e)Tj
1.32339 0 TD
0 Tc
(v)Tj
0.46511 0 TD
-0.01 Tc
(aluaci\227n y monitorizaci\227n. En Espa\226a la)Tj
-1.7885 -1.10001 TD
0.01 Tc
0 Tw
(ma)Tj
1.24169 0 TD
0 Tc
(y)Tj
0.51 0 TD
0.01 Tc
0.699 Tw
(or\222a de Com)Tj
6.45203 0 TD
0.644 Tw
(unidades Aut\227nomas)Tj
-8.20372 -1.10001 TD
-0.01 Tc
0.018 Tw
[((CCAA),)-258(carecen de programas para la erra-)]TJ
0 -1.1 TD
0.001 Tw
(dicaci\227n de la D)Tj
6.31404 0 TD
0 Tc
(Y)Tj
0.58302 0 TD
-0.01 Tc
(.)Tj
0.4636 0 TD
0 Tc
(T)Tj
0.52101 0 TD
-0.01 Tc
(an s\227lo han dispuesto de)Tj
-7.88167 -1.10001 TD
0.161 Tw
[(un programa de estas caracter\222sticas,)-346(Astu-)]TJ
0 -1.1 TD
-0.012 Tw
[(rias,)-227(Galicia,)-228(Extremadura y Catalu\226a,)-228(desta-)]TJ
T*
0.001 Tw
[(cando el de )55(Asturias que tras m\207s de 20 a\226os)]TJ
T*
-0.012 Tw
[(de se)15(guimiento ha logrado erradicar la D)55(Y)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 228.7502 336.4288 Tm
0 Tr
0 0 0 1 k
-0.01 Tc
0 Tw
(12)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 235.6103 333.1288 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
-16.04922 -2.20012 TD
-0.005 Tc
0.002 Tw
[(En Espa\226a la primera f)9(ase,)-247(se hab\222a cum-)]TJ
-1.13386 -1.1 TD
0.005 Tw
(plido pr\207cticamente entre los a\226os 80 y 90)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 231.1453 303.4276 Tm
0 Tr
0 0 0 1 k
-0.005 Tc
0 Tw
(22)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 63.7795 289.1276 Tm
0 Tr
0 0 0 1 k
-0.0052 Tc
(a)Tj
0.77439 0 Td
(e)Tj
0.42413 0 TD
-0.005 Tc
0 Tw
(xce)Tj
1.3727 0 TD
0.091 Tw
(pci\227n de Canta)Tj
6.10949 0 TD
0 Tw
(br)Tj
0.82277 0 TD
(ia,)Tj
1.29239 0 TD
0.091 Tw
(La Rioja,)Tj
4.05282 0 TD
0 Tw
[(V)111(alen-)]TJ
-14.84869 -1.10002 TD
0.033 Tw
(cia y Baleares \(de las dos \234ltimas se ha dis-)Tj
0 -1.1 TD
0.098 Tw
(puesto de inf)Tj
5.29571 0 TD
0 Tw
(or)Tj
0.82277 0 TD
0.098 Tw
(maci\227n m\207s r)Tj
5.52238 0 TD
0 Tw
(ecientemente\).)Tj
-11.64086 -1.10001 TD
0.098 Tw
(La gran mayor\222a de los estudios realizados)Tj
0 -1.1 TD
0.228 Tw
(indicaban que la pr\207ctica totalidad de las)Tj
T*
0.02 Tw
[(CCAA estaban con D)55(Y)129(. Las in)39(v)15(estig)5(aciones)]TJ
0 Tc
(r)'
0.32777 0 TD
-0.005 Tc
-0.03 Tw
[(ealizadas en )55(Asturias,)-215(Extr)-1(emadura,)-215(Galicia)]TJ
-0.32777 -1.1 TD
-0.0051 Tc
(y)Tj
0.72062 0 Td
-0.005 Tc
0 Tw
(Ca)Tj
1.10096 0 TD
-0.019 Tw
[(talu\226a sirvieron para dise\226ar los r)-1(espec-)]TJ
-1.82158 -1.1 TD
0 Tw
(ti)Tj
0.52077 0 TD
0 Tc
(v)Tj
0.47523 0 TD
-0.005 Tc
0.173 Tw
[(os programas de pre)25(v)15(enci\227n iniciados a)]TJ
-0.996 -1.10001 TD
0.164 Tw
[(f)20(inales de los a\226os ochenta. Otras CCAA,)]TJ
0 -1.1 TD
0.015 Tc
0.447 Tw
[(como )55(Andaluc\222a,)-712(Castilla-Le\227n y P)15(a\222s)]TJ
T*
-0.005 Tc
-0.037 Tw
[(V)111(asco,)-208(han realizado programas m\207s concre-)]TJ
T*
0.016 Tw
(tos que han inc)Tj
5.99848 0.00001 TD
(luido campa\226as para incenti-)Tj
-5.99848 -1.1 TD
0.127 Tw
[(v)25(ar el consumo de sal yodada,)-372(estudios de)]TJ
0 -1.10001 TD
0.003 Tw
[(pre)25(v)25(alencia de la D)54(Y)129(,)-248(y recomendaciones de)]TJ
0 -1.1 TD
0.209 Tw
[(suplementaci\227n durante la gestaci\227n,)-454(pero)]TJ
T*
0.134 Tw
(no siempr)Tj
4.0598 0 TD
-0.0051 Tc
(e)Tj
0.8173 0 Td
-0.005 Tc
0 Tw
(inmer)Tj
2.30744 0.00001 TD
0.134 Tw
(sas en un pr)Tj
5.08922 0.00001 TD
(ograma inte-)Tj
-12.2739 -1.1 TD
0.147 Tw
[(gral. Otro paso importante para la pre)25(v)15(en)-1(-)]TJ
T*
-0.017 Tw
[(ci\227n de la D)55(Y es que se utilice sal yodada en)]TJ
T*
-0.037 Tw
(los comedores escolares. Hasta este momen-)Tj
19.70079 52.80012 TD
0.055 Tw
[(to s\227lo es oblig)5(atorio en )54(Asturias y Galicia,)]TJ
0 -1.1 TD
-0.02 Tw
(aunque pr\227ximamente tambi\216n se establece-)Tj
T*
0.176 Tw
[(r\207 en )55(Andaluc\222a. Ser\222a deseable que todas)]TJ
T*
-0.016 Tw
[(las CCAA adoptaran esta medida. Probable)-1(-)]TJ
T*
0.056 Tw
[(mente en algunas zonas de Espa\226a,)-301(durante)]TJ
T*
-0.016 Tw
[(muchos a\226os ha f)10(allado la 4\273 f)9(ase,)-229(es decir la)]TJ
T*
0.039 Tw
[(v)20(oluntad y decisi\227n pol\222tica para afr)-1(ontar el)]TJ
T*
0.025 Tw
[(problema de los )17(TD)55(Y)129(.)]TJ
1.13386 -2.20013 TD
0 Tc
-0.01 Tw
[(La pre)25(v)15(enci\227n de la D)55(Y durante la g)-1(esta-)]TJ
-1.13386 -1.1 TD
0.017 Tw
[(ci\227n adquiere una gran rele)25(v)25(ancia dado que)]TJ
0 -1.10001 TD
0.012 Tw
[(una ingesta insuf)20(iciente de y)-1(odo implica un)]TJ
0 -1.1 TD
0.273 Tw
[(potencial riesgo para el feto. )54(Adem\207s el)]TJ
T*
0.166 Tw
(embarazo supone un aumento de m\207s del)Tj
T*
0.063 Tw
[(50% de los requerimientos de yodo,)-313(por lo)]TJ
T*
0.13 Tw
(que una ingesta adecuada de yodo en una)Tj
T*
0.105 Tw
[(mujer en edad f\216rtil puede ser insuf)20(iciente)]TJ
T*
-0.014 Tw
(cuando queda embar)Tj
8.24486 0 TD
0 Tw
(azada. )Tj
2.70604 0 TD
-0.014 Tw
(As\222 pues es dif\222)Tj
6.1494 0 TD
(-)Tj
-17.1003 -1.10001 TD
0.099 Tw
(cil que \234nicamente con la sal yodada pue-)Tj
0 -1.1 TD
0.018 Tw
[(dan cubrirse estos ele)24(v)25(ados requerimientos,)]TJ
T*
0.202 Tw
(siendo preciso en la mayor\222a de casos la)Tj
T*
0.071 Tw
(suplementaci\227n con 150-200 \265g de yoduro)Tj
T*
-0.032 Tw
[(pot\207sico,)-218(lo que se aconseja iniciar antes del)]TJ
T*
0.199 Tw
[(embarazo. Los pr)-1(imeros estudios entre la)]TJ
T*
0 Tw
(pob)Tj
1.5 0 TD
0.313 Tw
[(laci\227n gestante de di)25(v)15(er)-1(sas zonas de)]TJ
-1.5 -1.1 TD
0.067 Tw
(Espa\226a se han realizado en la \234ltima d\216ca-)Tj
T*
0 Tw
(da)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 270.2259 325.4276 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(25-33)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 286.5551 322.1276 Tm
0 Tr
0 0 0 1 k
0 Tc
(,)Tj
0.49639 0 TD
-0.004 Tw
(la ma)Tj
2.18975 0 TD
(y)Tj
0.5 0 TD
(or\222a se han desarrollado en el)Tj
-5.76291 -1.10001 TD
-0.034 Tw
[(primer trimestr)-1(e de la gestaci\227n,)-216(obteniendo)]TJ
0 -1.1 TD
-0.014 Tw
[(resultados similares que ponen de manif)20(ies-)]TJ
T*
0.093 Tw
(to una insuf)Tj
4.88793 0 TD
(iciente ing)Tj
4.28613 0 TD
(esta de y)Tj
3.68481 0 TD
(odo en una)Tj
-12.85887 -1.10001 TD
0.06 Tw
[(ele)25(v)25(ada pr)-1(oporci\227n de las mujeres embara-)]TJ
0 -1.1 TD
0 Tw
(zadas. )Tj
2.7766 0 TD
(T)Tj
0.53101 0 TD
0.074 Tw
(odos estos estudios pr)Tj
8.97044 0 TD
(esentan unas)Tj
-12.27805 -1.10001 TD
0.17 Tw
[(medianas infer)-1(iores a 150 \265g/L,)-420(punto de)]TJ
0 -1.1 TD
0.004 Tw
(corte por encima del cual la OMS establece)Tj
T*
0.009 Tw
(que la poblaci\227n gestante tiene una adecua-)Tj
T*
-0.018 Tw
(da n)Tj
1.67604 0 TD
(utrici\227n de yodo)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 342.7311 226.4276 Tm
0 Tr
0 0 0 1 k
0 Tc
(4)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 346.2311 223.1276 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
0.42725 0 TD
-0.018 Tw
(Ante estos resultados)Tj
-8.97162 -1.1 TD
-0.004 Tw
(algunas CCAA como el P)Tj
10.30198 0 TD
-0.054 Tw
[(a\222s V)111(asco )-50(y )4(Anda-)]TJ
-10.30198 -1.1 TD
0.055 Tw
(luc\222a han incor)Tj
6.05101 0 TD
0 Tw
(por)Tj
1.33276 0 TD
0.055 Tw
(ado en sus protocolos de)Tj
-7.38377 -1.10001 TD
0.094 Tw
[(control del embaraz)-1(o la recomendaci\227n de)]TJ
0 -1.1 TD
0.025 Tw
(suplementar con yoduro pot\207sico.)Tj
1.42627 -3.29997 TD
0 Tw
(CONTR)Tj
3.34888 0.00001 TD
(OL )Tj
1.51792 0.00001 TD
-0.0001 Tc
(Y)Tj
0.99677 0 Td
0 Tc
(MONIT)Tj
3.2587 0 TD
[(ORIZA)40(CI\356N)]TJ
-6.97393 -1.10002 TD
0.025 Tw
(DE LA D)Tj
3.88252 0 TD
-0.0001 Tc
(Y)Tj
0.99681 0 Td
0 Tc
(EN ESP)Tj
3.23874 0 TD
0 Tw
(A\204A)Tj
-10.55882 -2.20014 TD
0.005 Tc
0.087 Tw
[(T)70(endr\222a m\207s sentido hablar de la moni-)]TJ
-1.13386 -1.1 TD
0 Tw
(tor)Tj
1.12559 0.00001 TD
0.02 Tw
(izaci\227n y contr)Tj
6.05633 0.00001 TD
(ol de los programas dise-)Tj
-7.18192 -1.10002 TD
0.204 Tw
[(\226ados para la erradicaci\227n de la D)55(Y)129(,)-459(sin)]TJ
0 -1.1 TD
0.326 Tw
[(embar)18(go ya se ha comentado que muy)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
8 0 0 8 63.7795 53.9363 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(Re)25(v Esp Salud P\234blica 2008,)-226(V)129(ol. 82,)-275(N.\241)-274(4)-27412(373)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
6 0 0 6 241.3652 647.7751 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(PREVENCI\356N )90(Y CONTR)39(OL DE LA DEFICIENCIA DE )90(Y)30(ODO EN ESP)92(A\204A)]TJ
ET
Q

endstream
endobj
8 0 obj
<<
/Length 11094
>>
stream
/GS0 gs
q
0 0.654 498 691 re
W n
1 g
0 691.654 0 0 re
f
Q
/GS1 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 63.7795 608.1288 Tm
0 Tr
0 0 0 1 k
0.009 Tc
0.371 Tw
[(pocas CCAA han elaborado progr)1(amas)]TJ
0 -1.1 TD
0.005 Tc
-0.028 Tw
[(completos para este f)20(in por lo que,)-227(en gene-)]TJ
T*
-0.015 Tw
[(ral,)-240(se suelen e)25(v)25(aluar directamente los indi-)]TJ
T*
0.25 Tw
(cadores de la yodaci\227n en la poblaci\227n.)Tj
T*
0.023 Tw
[(Se)15(g\234n la OMS,)-278(para conse)15(guir una progre-)]TJ
T*
0.107 Tw
[(si)25(v)25(a y sostenible er)-1(r)1(adicaci\227n de los )17(TD)55(Y)]TJ
T*
0.039 Tw
[(deber\222an cumplirse toda una serie de crite)-1(-)]TJ
T*
0.011 Tw
[(rios que v)25(an desde la e)15(xistencia de comit\216s)]TJ
0 -1.10001 TD
0.0049 Tc
(de)Tj
1.49473 0 Td
0.005 Tc
0.286 Tw
[(e)15(xpertos,)-541(inc)-1(lusi\227n de los progr)1(amas)]TJ
-1.49473 -1.1 TD
0.004 Tw
[(para la erradicaci\227n de los )18(TD)54(Y en los pre-)]TJ
T*
0.017 Tc
0.363 Tw
[(supuestos anuales,)-630(le)14(g)1(islaci\227n sobr)-1(e la)]TJ
T*
0.005 Tc
0.189 Tw
[(yodaci\227n que promue)25(v)24(a la yodaci\227n uni-)]TJ
T*
0.051 Tw
[(v)15(ersal,)-307(e)15(xistencia de sistemas rutinarios de)]TJ
T*
0.12 Tw
[(control de la e)25(v)19(oluci\227n de los )18(TD)55(Y)129(,)-375(de la)]TJ
0 Tc
(y)'
0.505 0 TD
0.005 Tc
0.071 Tw
(oduria de la poblaci\227n y de la calidad de)Tj
-0.505 -1.1 TD
0.083 Tw
[(la sal yodada,)-339(y e)15(xistencia de una base de)]TJ
T*
0.119 Tw
(datos estatal que monitorice los indicado-)Tj
T*
0.154 Tw
[(res de la e)25(v)20(oluci\227n de los )18(TD)54(Y)129(. )55(Adem\207s,)]TJ
0 Tc
(r)'
0.33776 0 TD
0.005 Tc
0 Tw
(ef)Tj
0.78661 0 TD
-0.018 Tw
[(erente a la poblaci\227n,)-238(deber\222a conse)15(guir-)]TJ
-1.12437 -1.10001 TD
0.04 Tw
(se que el 90% de las f)Tj
9.05661 0 TD
(amilias consumier)Tj
7.42763 0 TD
0 Tw
(an)Tj
-16.48424 -1.10001 TD
0.023 Tw
(sal adecuadamente yodada y que la media-)Tj
0 -1.1 TD
0.186 Tw
(na de y)Tj
3.29528 0 TD
0.0049 Tc
(odur)Tj
1.85275 0 TD
0.005 Tc
0 Tw
(ia,)Tj
1.42797 0 TD
0.186 Tw
(como mar)Tj
4.2524 0 TD
(cador m\207s r)Tj
5.09138 0 TD
0 Tw
(ele-)Tj
-15.91978 -1.10002 TD
0.311 Tw
[(v)25(ante de la yodaci\227n poblacional,)-566(fuera)]TJ
0 -1.1 TD
0.001 Tw
(entre 100 y 199 \265g/L en la poblaci\227n gene-)Tj
T*
0.046 Tw
(ral y de entre 150 y 249 \265g/L en las muje-)Tj
T*
0.025 Tw
(res gestantes)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 115.4848 336.4288 Tm
0 Tr
0 0 0 1 k
0.005 Tc
0 Tw
(34)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 122.5548 333.1288 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
-4.74367 -2.20012 TD
-0.023 Tw
(Los mejores resultados en el consumo de)Tj
-1.13386 -1.1 TD
0.196 Tw
[(sal yodada son los de )50(V)111(alencia)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 194.9774 303.4276 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(18)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 206.4367 300.1276 Tm
0 Tr
0 0 0 1 k
0 Tc
(y)Tj
0.891 0 Td
0 Tw
(Astu-)Tj
-15.15672 -1.1 TD
(r)Tj
0.33277 0 TD
(ias)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 78.2131 292.4276 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(12)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 88.3166 289.1276 Tm
0 Tr
0 0 0 1 k
0 Tc
0.06 Tw
(que sin lle)Tj
4.21592 0 TD
(g)Tj
0.49512 0 TD
(ar al 90% est\207n por enci)Tj
9.93555 0 TD
(-)Tj
-17.1003 -1.10001 TD
0.031 Tw
(ma del 70%. Respecto al control de la cali-)Tj
0 -1.1 TD
(dad de la sal no ha)Tj
7.57006 0 TD
-0.0001 Tc
(y)Tj
0.78105 0 Td
0 Tc
0 Tw
(inf)Tj
1.11079 0 TD
(or)Tj
0.83276 0 TD
0.031 Tw
(maci\227n accesib)Tj
6.16675 0 TD
0 Tw
(le)Tj
0.72168 0 TD
(,)Tj
-17.18309 -1.10002 TD
0.068 Tw
(aunque recientemente UNICEF ha suscrito)Tj
0 -1.1 TD
0.061 Tw
(un acuerdo con algunas empresas salineras)Tj
T*
0.12 Tw
(que producir\207n sal yodada por un proceso)Tj
T*
0 Tw
(homolo)Tj
3.05567 0 TD
[(g)5(ado por la OMS. En 1995 se anali-)]TJ
-3.05567 -1.1 TD
0.107 Tw
(z\227 una m)Tj
3.87869 0 TD
(uestra de paquetes de sal yodada)Tj
-3.87869 -1.1 TD
0.119 Tw
(en distintos comer)Tj
7.57014 0 TD
(cios de Cuenca:)Tj
6.93907 0 TD
(el 60%)Tj
-14.50921 -1.10001 TD
0.075 Tw
(ten\222an un 15% menos de yodo del estable-)Tj
0 -1.1 TD
0.025 Tw
[(cido y un 18% un contenido e)15(xcesi)25(v)19(o)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 214.6448 182.4276 Tm
0 Tr
0 0 0 1 k
0 Tc
(35)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 221.6448 179.1276 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
-14.65267 -2.20013 TD
0.026 Tw
[(P)15(ara conocer el impacto de un pr)-1(ogr)1(ama)]TJ
-1.13386 -1.1 TD
0.054 Tw
(de y)Tj
1.74821 0.00001 TD
(odaci\227n la OMS inc)Tj
8.1887 0.00001 TD
0 Tw
(luy)Tj
1.27783 0 TD
-0.0001 Tc
(e)Tj
0.74818 0 Td
0 Tc
0.054 Tw
(los siguientes)Tj
-11.96292 -1.10002 TD
0.143 Tw
[(indicadores:)-393(La yoduria,)-393(la pre)25(v)25(alencia de)]TJ
0 -1.1 TD
0.105 Tw
[(bocio,)-355(la medici\227n de la tiroglob)20(ulina y el)]TJ
T*
0.013 Tw
(an\207lisis de la tir)Tj
6.34287 0.00001 TD
(otropina neonatal. El c\207lcu-)Tj
-6.3429 -1.1 TD
0.083 Tw
[(lo de la mediana de yoduria de una pobla)-1(-)]TJ
T*
0.02 Tc
0.401 Tw
[(ci\227n \(prefer)-1(iblemente escolar/gestante\),)]TJ
T*
0 Tc
0.032 Tw
[(como se ha comentado anteriormente,)-282(es el)]TJ
19.70079 52.80025 TD
0.088 Tw
[(indicador m\207s potente y f)10(actible )-1(p)1(a)-1(ra def)20(i-)]TJ
0 -1.1 TD
0.145 Tw
(nir el estado de nutrici\227n de yodo de una)Tj
T*
0.094 Tw
[(poblaci\227n. En el apartado sobre la pre)25(v)14(en-)]TJ
T*
0.258 Tw
(ci\227n se han enumerado los trabajos m\207s)Tj
T*
0.001 Tc
0.374 Tw
[(rele)24(v)25(antes que presentan unas medianas)]TJ
T*
0 Tc
0.068 Tw
[(superiores a 100 \265g/L. Otros estudios tam)-1(-)]TJ
T*
0.082 Tw
(bi\216n han presentado resultados alentadores)Tj
T*
0.186 Tw
(en algunas de estas zonas como en Gali-)Tj
0 -1.10001 TD
0 Tw
(cia)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 272.4427 523.4288 Tm
0 Tr
0 0 0 1 k
0 Tc
(1)Tj
0.5 0.00001 TD
0 Tw
(1,36)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 288.1926 520.1288 Tm
0 Tr
0 0 0 1 k
0 Tc
-0.004 Tw
[(,)-246(los ya citados de )50(V)111(alencia y )55(Alican)-1(-)]TJ
-2.74052 -1.1 TD
-0.089 Tw
[(te,)-216(en Andal)-1(uc\222a)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 324.8056 512.4288 Tm
0 Tr
0 0 0 1 k
0 Tc
(1)Tj
0.5 0.00001 TD
0 Tw
(5,37)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 340.5555 509.1288 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
[(,)-216(Mallorca)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 381.3048 512.4288 Tm
0 Tr
0 0 0 1 k
0 Tc
(3)Tj
0.5 0.00001 TD
(8)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 390.4652 509.1288 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(y)Tj
0.71591 0 Td
0 Tc
-0.034 Tw
[(en el P)15(a\222s)]TJ
-13.6837 -1.1 TD
0.365 Tw
[(V)111(asco (datos a\234n no publicados),)-616(todos)]TJ
T*
0.088 Tw
[(ellos realizados en poblaci\227n escolar)55(. Des-)]TJ
T*
0.239 Tw
(taca la discordancia detectada en Galicia)Tj
T*
0.038 Tw
(entre los resultados obtenidos en poblaci\227n)Tj
T*
0.276 Tw
(escolar con unas medianas de 102,9)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 417.8591 457.4288 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(11)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 430.1181 454.1288 Tm
0 Tr
0 0 0 1 k
0 Tc
(y)Tj
-16.93307 -1.1 TD
0.202 Tw
(115,7 \265g/L)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 306.6918 446.4288 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(36)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 318.2094 443.1288 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(y)Tj
0.95161 0 Td
0 Tc
0.202 Tw
(la detectada en poblaci\227n)Tj
-6.69382 -1.1 TD
0.064 Tw
(adulta que es de 75,6 \265g/L. Probablemente)Tj
T*
0.075 Tw
[(esta difer)-1(encia teng)5(a relaci\227n con que s\227lo)]TJ
T*
0.258 Tw
(el 40% de la pob)Tj
7.75348 0 TD
(laci\227n adulta estudiada)Tj
-7.75348 -1.1 TD
0.079 Tw
(consum\222a sal y)Tj
6.09994 0 TD
0 Tw
(odada,)Tj
2.96624 0 TD
-0.0001 Tc
(y)Tj
0.82842 0 Td
0 Tc
0.079 Tw
(en cambio su con)Tj
7.2057 0 TD
(-)Tj
-17.1003 -1.10001 TD
0.075 Tw
(sumo es generalizado en la mayor\222a de los)Tj
0 -1.1 TD
0 Tw
(comedor)Tj
3.49829 0 TD
0.023 Tw
(es escolar)Tj
3.93668 0 TD
(es de Galicia. )Tj
5.67723 0 TD
-0.0001 Tc
(A)Tj
0.99467 0 Td
0 Tc
(pesar de)Tj
-14.10687 -1.10001 TD
0.129 Tw
(que los resultados actuales en general son)Tj
0 -1.1 TD
-0.028 Tw
[(b)20(uenos,)-223(e)15(xiste un gr)1(an n\234mero de CCAA en)]TJ
T*
-0.008 Tw
(la que los datos conocidos tienen m\207s de 10)Tj
T*
0.033 Tw
[(a\226os y deber\222an actualizarse:)-228(Ar)-1(a)1(g\227n,)-283(Mur-)]TJ
T*
-0.003 Tw
[(cia,)-248(Na)20(v)25(ar)-1(r)1(a,)-248(Extremadura,)-248(Castilla la Man-)]TJ
T*
0.031 Tw
[(cha,)-281(Cantabria y la Rioja \(en \216stas dos \234lti-)]TJ
T*
0.02 Tc
0.708 Tw
(mas com)Tj
4.43006 0 TD
[(unidades no e)15(xiste ning\234n)]TJ
-4.43006 -1.1 TD
0 Tc
-0.029 Tw
[(estudio\). Pre)25(viamente se ha indicado el bajo)]TJ
T*
0.147 Tw
(consumo de y)Tj
5.84919 0 TD
(odo que r)Tj
4.07136 0 TD
0 Tw
(ef)Tj
0.77661 0 TD
0.147 Tw
(lejan la mayor\222a)Tj
-10.69716 -1.10001 TD
0.027 Tw
(de estudios realizados en poblaci\227n gestan-)Tj
0 -1.1 TD
0.018 Tw
(te coincidiendo con que est\207n realizados en)Tj
T*
-0.005 Tw
(el pr)Tj
1.79903 0 TD
(imer tr)Tj
2.68745 0 TD
0 Tw
(imestr)Tj
2.49902 0 TD
-0.0001 Tc
(e)Tj
0.68842 0 Td
0 Tc
-0.005 Tw
(de la g)Tj
2.6547 0 TD
0 Tw
(estaci\227n. )Tj
3.71577 0 TD
(Algunos)Tj
-14.0444 -1.10002 TD
0.147 Tw
(de estos mismos estudios ponen de mani-)Tj
0 -1.1 TD
(f)Tj
0.31299 0 TD
-0.025 Tw
(iesto c\227mo la y)Tj
6.00742 0 TD
0 Tw
(odur)Tj
1.83276 0 TD
-0.025 Tw
(ia alcanza las r)Tj
5.83775 0 TD
0 Tw
(ecomen)Tj
3.10938 0 TD
(-)Tj
-17.1003 -1.10002 TD
0.027 Tw
(daciones de la OMS cuando son suplemen-)Tj
0 -1.1 TD
0.025 Tw
(tadas con y)Tj
4.54829 0 TD
(oduro pot\207sico)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 365.6707 204.4288 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(26,33,40)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 390.1707 201.1288 Tm
0 Tr
0 0 0 1 k
0 Tc
(.)Tj
-11.80447 -2.20012 TD
-0.001 Tw
[(La pre)25(v)25(alencia de bocio determinada por)]TJ
-1.13386 -1.1 TD
0.068 Tw
(palpaci\227n manual ha sido tradicionalmente)Tj
T*
0.001 Tw
(el m\216todo m\207s empleado,)Tj
10.47148 0.00001 TD
[(por su f)10(acilidad y)]TJ
-10.47148 -1.1 TD
0.002 Tc
0.373 Tw
[(ele)25(v)24(ada concordancia entre e)15(xploradores)]TJ
0 -1.10001 TD
0 Tc
-0.025 Tw
(entrenados. En los \234ltimos a\226os se ha incor-)Tj
0 -1.1 TD
0.222 Tw
(porado la ecograf\222a para la medici\227n del)Tj
(v)'
0.48022 0.00001 TD
0.143 Tw
(olumen tir)Tj
4.28045 0.00001 TD
(oideo aunque pr)Tj
6.72716 0.00001 TD
(esenta algunas)Tj
-11.48783 -1.10002 TD
0.17 Tw
[(dif)20(icultades par)-1(a establecer los v)25(alores de)]TJ
0 -1.1 TD
0 Tw
(normalidad)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 306.3269 94.4276 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(41)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 313.3269 91.1276 Tm
0 Tr
0 0 0 1 k
-0.0001 Tc
(.)Tj
0.60831 0 Td
0 Tc
0.108 Tw
(En algunos estudios realiza-)Tj
-5.86226 -1.1 TD
0.119 Tw
[(dos en zonas en f)10(ase de eliminaci\227n de la)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
6 0 0 6 63.7795 647.7751 Tm
0 Tr
0 0 0 1 k
0 Tc
-0.025 Tw
[(Ll. V)60(ila)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
8 0 0 8 63.7795 53.9363 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(374)-27412(Re)25(v Esp Salud P\234blica 2008,)-225(V)128(ol. 82,)-275(N)1<2EA1>-275(4)]TJ
ET
Q

endstream
endobj
9 0 obj
<<
/Length 9790
>>
stream
/GS0 gs
q
0 0.654 498 691 re
W n
1 g
0 691.654 0 0 re
f
Q
/GS1 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 63.7795 608.1288 Tm
0 Tr
0 0 0 1 k
0 Tc
0.122 Tw
[(D)55(Y la pre)25(v)25(alencia de bocio puede ser a\234n)]TJ
0 -1.10309 TD
0.248 Tw
[(superior al 5% \(indicati)24(v)20(o de D)55(Y\) y sin)]TJ
0 -1.1031 TD
0.242 Tw
[(embar)18(go tener una adecuada mediana de)]TJ
T*
0.18 Tw
(yoduria. Este fen\227meno se describe en el)Tj
0 -1.10309 TD
-0.019 Tw
[(estudio de )50(V)111(alencia)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 140.6372 567.3052 Tm
0 Tr
0 0 0 1 k
0 Tc
(1)Tj
0.5 0.00001 TD
(8)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 149.9429 564.0052 Tm
0 Tr
0 0 0 1 k
0 Tc
-0.019 Tw
(pero no es m\207s que un)Tj
-8.61634 -1.10309 TD
0.069 Tw
[(desf)10(ase en el tiempo. La tir)-1(oglob)20(ulina,)-319(a\234n)]TJ
0 -1.1031 TD
-0.036 Tw
[(presentando una muy b)19(uena corr)1(elaci\227n con)]TJ
0 -1.10309 TD
0.006 Tw
[(el v)20(olumen de la gl\207ndula tiroides se utiliza)]TJ
T*
0.116 Tw
(muy limitadamente debido a que encarece)Tj
T*
0.025 Tw
(notablemente los estudios)Tj
1.13386 -2.20322 TD
0.101 Tw
[(P)15(arad\227jicamente)-1(,)-350(siendo la medici\227n de)]TJ
-1.13386 -1.10309 TD
0.194 Tw
[(la tirotropina neonatal un hec)-1(ho pr\207ctica-)]TJ
T*
0.094 Tw
[(mente uni)25(v)15(er)-1(sal en nuestro pa\222s,)-344(apenas se)]TJ
T*
0.062 Tw
[(ha utilizado como indicador de D)55(Y)129(. Proba-)]TJ
T*
0.049 Tw
[(blemente,)-299(el a\234n e)15(xtendido uso de los anti-)]TJ
0 -1.1031 TD
0.004 Tc
0.371 Tw
(s\216pticos y)Tj
4.38478 0 TD
(odados dur)Tj
4.82912 0 TD
(ante el parto y el)Tj
-9.2139 -1.1031 TD
0 Tc
0.003 Tw
[(momento de recogida de la muestr)-1(a dif)20(icul-)]TJ
0 -1.10309 TD
0.055 Tw
[(tan la v)25(aloraci\227n de los resultados en algu)-1(-)]TJ
T*
-0.017 Tw
(nas CCAA. Uno de los aspectos m\207s intere-)Tj
T*
0.202 Tw
(santes del estudio que se pub)Tj
12.58819 0 TD
(lica en este)Tj
-12.58819 -1.1031 TD
0 Tw
(n\234mer)Tj
2.55445 0 TD
(o)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 94.324 379.8093 Tm
0 Tr
0 0 0 1 k
0 Tc
0 Tw
(20)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 103.6687 376.5093 Tm
0 Tr
0 0 0 1 k
0 Tc
-0.016 Tw
(ha sido justamente poner de r)Tj
11.66802 0 TD
0 Tw
(elie)Tj
1.44336 0 TD
(-)Tj
-17.1003 -1.10309 TD
0.041 Tw
[(v)15(e los efectos de ambos artef)9(actos metodo-)]TJ
0 -1.1031 TD
0 Tw
(l\227g)Tj
1.27783 0 TD
0.029 Tw
[(icos y apo)10(ya clar)-1(amente la necesidad de)]TJ
-1.27783 -1.10309 TD
0.008 Tw
(que la prohibici\227n de los antis\216pticos yoda-)Tj
T*
0.309 Tw
[(dos se e)15(xtienda a todas las CCAA. )18(T)80(al)]TJ
T*
0.074 Tw
(como a)Tj
2.98999 0 TD
(puntan en la discusi\227n si las condi)Tj
14.11033 0 TD
(-)Tj
-17.10032 -1.1031 TD
0.004 Tw
(ciones para el an\207lisis de la tirotropina neo-)Tj
0 -1.10309 TD
0 Tw
(na)Tj
0.94385 0 TD
0.092 Tw
(tal fuer)Tj
2.95052 0 TD
(an \227ptimas en todas las Com)Tj
11.92811 0 TD
0 Tw
(uni-)Tj
-15.82248 -1.1031 TD
0.02 Tc
(dades,)Tj
3.54364 0 TD
0.627 Tw
(se dispondr\222a de un v)Tj
11.40103 0 TD
0 Tw
(alioso)Tj
-14.94467 -1.10311 TD
0 Tc
0.163 Tw
[(instrumento para monitorizar la e)24(v)20(oluci\227n)]TJ
0 -1.10309 TD
0.025 Tw
(de la D)Tj
2.88252 0 TD
(Y)Tj
0.59302 0 TD
(.)Tj
-2.34168 -2.20322 TD
0.057 Tw
[(De acuerdo con Barona-V)59(illar y colabo-)]TJ
-1.13386 -1.1031 TD
(r)Tj
0.33277 0 TD
0 Tw
(ador)Tj
1.77661 0 TD
(es,)Tj
1.30245 0 TD
-0.03 Tw
(una limitaci\227n ob)Tj
6.92302 0 TD
(via de este tipo de)Tj
-10.33485 -1.1031 TD
0.193 Tw
(estudios es la imposibilidad de contrastar)Tj
0 -1.10309 TD
0.225 Tw
(los r)Tj
1.97478 0 TD
(esultados con la ingesta de yodo en)Tj
-1.97478 -1.10309 TD
0.138 Tw
(forma de sal yodada o suplementos yoda-)Tj
T*
-0.011 Tw
[(dos,)-239(por lo que realmente ser\222a no s\227lo inte-)]TJ
T*
0.049 Tw
(resante sino necesario disponer de estudios)Tj
T*
0 Tw
(entr)Tj
1.55445 0.00001 TD
-0.0001 Tc
(e)Tj
0.96564 0 Td
0 Tc
0.272 Tw
(la pob)Tj
2.74344 0.00001 TD
(laci\227n g)Tj
3.46513 0.00001 TD
(estante par)Tj
4.5745 0.00001 TD
-0.0001 Tc
(a)Tj
0.96556 0 Td
0 Tc
0 Tw
(conocer)Tj
-14.26871 -1.10313 TD
0.074 Tw
(cu\207l es la fuente que principalmente deter-)Tj
0 -1.10309 TD
0.297 Tw
[(mina su yoduria. )55(Aunque probablemente)]TJ
0 -1.1031 TD
0.083 Tw
[(los resultados del estudio de Barona-V)60(illar)]TJ
0 -1.10309 TD
0.009 Tw
(puedan r)Tj
3.47904 0.00001 TD
0 Tw
(elacionar)Tj
3.66382 0.00001 TD
0.009 Tw
(se con los obtenidos en el)Tj
-7.1429 -1.1031 TD
0.003 Tc
0.372 Tw
[(estudio de Pe)1(ris y colaboradore)1(s)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
7 0 0 7 208.915 115.097 Tm
0 Tr
0 0 0 1 k
0.003 Tc
0 Tw
(18)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
10 0 0 10 215.9522 111.797 Tm
0 Tr
0 0 0 1 k
0.003 Tc
0 Tw
[(,)-625(por)]TJ
-15.2173 -1.1031 TD
0 Tc
0.194 Tw
[(haberse r)-1(ealizado )1(ambos en la Com)-1(unitat)]TJ
T*
0.265 Tw
[(V)111(alenciana,)-515(la f)9(alta de un programa que)]TJ
T*
0.09 Tw
[(af)19(iance la disponibilidad de sal yodada,)-340(su)]TJ
19.70079 52.94246 TD
-0.028 Tw
(adecuada yodaci\227n y que peri\227dicamente se)Tj
0 -1.10839 TD
0.064 Tw
[(promue)24(v)25(a su consumo,)-314(siempre implica un)]TJ
T*
0.035 Tw
[(cierto riesgo de que pudier)-1(a darse un retro-)]TJ
T*
0.008 Tw
[(ceso,)-258(y este fen\227meno podr\222a darse en otras)]TJ
T*
0.134 Tw
(CCAA. Mientras la yodaci\227n de la sal no)Tj
T*
0.01 Tw
[(sea de car\207cter uni)25(v)15(er)-1(sal el riesgo del retro-)]TJ
0 -1.10838 TD
0.014 Tw
[(ceso siempre e)15(xiste si no se establecen pr)-1(o-)]TJ
0 -1.10839 TD
0.138 Tw
(gramas que contemplen las medidas men-)Tj
T*
0.189 Tw
[(cionadas. )55(Aunque el estudio de Barona y)]TJ
T*
0.291 Tw
[(colaboradores tr)-1(aduce una muy probable)]TJ
0 -1.10838 TD
0.095 Tw
[(b)20(uena nutrici\227n de y)-1(odo de esta poblaci\227n)]TJ
0 -1.10839 TD
0.124 Tw
(gestante \(\300por suplementaci\227n con yoduro)Tj
T*
0.122 Tw
[(pot\207sico?\),)-372(la mayor\222a de estudios realiza-)]TJ
T*
0.095 Tw
[(dos en otras CCAA indican una def)20(iciente)]TJ
(n)'
0.5 0 TD
-0.009 Tw
[(utrici\227n de yodo,)-241(por lo que se debe se)15(guir)]TJ
-0.5 -1.10838 TD
0.02 Tc
0.565 Tw
(recomendando la suplementaci\227n con)Tj
0 -1.10839 TD
0 Tc
-0.012 Tw
[(yoduro pot\207sico durante el embaraz)-1(o y si es)]TJ
T*
0 Tw
(posib)Tj
2.16675 0 TD
0.025 Tw
(le en el per)Tj
4.48882 0 TD
(iodo preconcepcional.)Tj
-1.46589 -3.30834 TD
0 Tw
(BIBLIOGRAF\352A)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
8 0 0 8 260.7874 368.5355 Tm
0 Tr
0 0 0 1 k
0 Tc
0.035 Tw
[(1.)-1016(Hetzel BS. Iodine def)20(icienc)14(y disorders (IDD) and)]TJ
1.76563 -1.13549 TD
0.025 Tw
(their eradication. Lancet. 1983; 2(8359):1126-29.)Tj
-1.76563 -2.26048 TD
0 Tw
(2.)Tj
1.76563 0 TD
(WHO)Tj
2.3877 0 TD
-0.0001 Tc
(.)Tj
0.51565 0 Td
0 Tc
0.016 Tw
(Iodine Def)Tj
4.29924 0 TD
0 Tw
(icienc)Tj
2.37231 0 TD
-0.0001 Tc
(y)Tj
0.76567 0 Td
0 Tc
0.016 Tw
(in Eur)Tj
2.48744 0 TD
[(ope:)-211(A continuing)]TJ
-12.82801 -1.13551 TD
-0.02 Tw
[(public health problem. )55(Anderson M,)-231(de Benoist B,)]TJ
0 -1.13547 TD
-0.028 Tw
[(Darnton-Hill I,)-222(Delang)-1(e F)80(,)-222(editors. Gene)25(v)25(a:)-193(WHO;)]TJ
0 -1.13549 TD
0.001 Tc
0.374 Tw
[(2007. Disponibl)1(e)1( )1(e)1(n)1(:)-624(h)1(t)1(t)1(p)1(:)1(/)1(/)1(w)1(w)1(w)66(.)1(who.int/nu)1(t)1(r)1(i)1(-)]TJ
0 -1.13548 TD
0.008 Tc
0 Tw
[(tion/publications/VMNIS_Iodine_def)19(icienc)15(y_in_)]TJ
0 -1.13549 TD
0 Tc
(Europe.pdf.)Tj
-1.76563 -2.26047 TD
0.067 Tw
[(3.)-1016(WHO UI. )30(WHO,)-317(UNICEF)80(,)-318(ICCIDD. )55(Assessment)]TJ
1.76563 -1.13549 TD
0.352 Tw
[(of iodine def)20(icienc)14(y disorders and monitoring)]TJ
0 -1.13548 TD
0.121 Tw
[(their elimination. )55(A guide for pr)-1(ogr)1(amme mana-)]TJ
0 -1.13549 TD
0.234 Tw
[(gers,)-484(2nd ed,)-455(WHO/NHD/01.1,)-484(Gene)25(v)25(a:)-454(WHO;)]TJ
0 -1.13548 TD
0.019 Tc
0.356 Tw
(2001. [consultado 29-09-06]:)Tj
13.56207 0 TD
0 Tw
(Disponib)Tj
3.81909 0 TD
0.356 Tw
(le en:)Tj
-17.38116 -1.13549 TD
0.214 Tc
0 Tw
[(http://www)65(.who.int/reproducti)24(v)15(e-)]TJ
0 -1.13548 TD
0 Tc
0.025 Tw
[(health/docs/iodine_def)20(icienc)14(y)65(.pdf. 2001.)]TJ
-1.76563 -2.26049 TD
0 Tw
(4.)Tj
1.76563 0 TD
0.19 Tw
[(ICCIDD. Iodine requeriments in pre)15(gnanc)14(y and)]TJ
0 -1.13548 TD
0.006 Tc
0.369 Tw
[(inf)10(anc)14(y)65(. http://www)65(.euroth)5(yr)-1(oid.com/documents)]TJ
0 -1.13547 TD
0 Tc
0.025 Tw
[(/IDD-NL-Feb07.pdf IDD Ne)25(wsletter 2007:)-275(1-2.)]TJ
-1.76563 -2.26049 TD
0.091 Tw
[(5.)-1016(F)15(ood and Nutrition Board. Institute of Medicine.)]TJ
1.76563 -1.13549 TD
0.03 Tw
[(Dietary Refer)-1(ence Intak)10(es for )49(V)60(itamin )55(A,)-230(V)60(itamin)]TJ
0 -1.13548 TD
0 Tw
[(K,)-437(Arsenic,)-492(Boron,)-492(Chromium,)-492(Copper)40(,)-492(Iodine,)]TJ
0 -1.13549 TD
(Ir)Tj
0.66552 0.00001 TD
(on,)Tj
1.67116 0.00001 TD
(Mang)Tj
2.32789 0.00001 TD
(anese)Tj
2.22045 0.00001 TD
(,)Tj
0.67116 0.00001 TD
(Mol)Tj
1.66675 0.00001 TD
(ybden)Tj
2.44385 0.00001 TD
[(um,)-421(Nick)9(el,)-421(Silicon,)]TJ
-11.66679 -1.13553 TD
0.035 Tw
[(V)111(anadium,)-285(and Zinc. National )54(Academy Press )30(W)37(;)]TJ
0 -1.13549 TD
0.343 Tw
[(2004. Disponible en:)-594(http://books.nap.edu/cata-)]TJ
0 -1.13548 TD
0 Tw
(lo)Tj
0.77784 0.00001 TD
(g/10026.html.)Tj
-2.54346 -2.2605 TD
(6.)Tj
1.76563 0.00001 TD
(F)Tj
0.50192 0.00001 TD
0.02 Tc
0.543 Tw
[(A)55(O/WHO e)15(xpert consultation. Iodine. In:)]TJ
-0.50192 -1.1355 TD
0 Tc
(F)Tj
0.48194 -0.00001 TD
0.127 Tw
[(A)55(O/WHO,)-377(editor)55(. )50(V)60(itamin and mineral r)-1(equire-)]TJ
-0.48194 -1.13547 TD
0.015 Tc
0.359 Tw
[(ments in human nutrition:)-625(r)-1(eport of a joint)]TJ
-26.3916 -3.0418 TD
0 Tc
0.025 Tw
[(Re)25(v Esp Salud P\234blica 2008,)-226(V)129(ol. 82,)-275(N.\241)-274(4)-27412(375)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
6 0 0 6 241.3652 647.7751 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(PREVENCI\356N )90(Y CONTR)39(OL DE LA DEFICIENCIA DE )90(Y)30(ODO EN ESP)92(A\204A)]TJ
ET
Q

endstream
endobj
10 0 obj
<<
/Length 10496
>>
stream
/GS0 gs
q
0 0.654 498 691 re
W n
1 g
0 691.654 0 0 re
f
Q
/GS1 gs
/GS2 gs
q
BT
/F0 1 Tf
8 0 0 8 77.9045 609.5268 Tm
0 Tr
0 0 0 1 k
0 Tc
0.158 Tw
[(F)74(A)55(O/WHO e)15(xpert consultation. Bangk)9(ok:)-378(WHO)]TJ
0 -1.125 TD
0.075 Tw
[(Librar)-1(y Cataloguing-in-Publication Data; 1998.p.)]TJ
0 -1.12499 TD
0 Tw
(303-17.)Tj
-1.76563 -2.25 TD
0.192 Tw
[(7.)-1016(Hetzel BS. )18(The Story of Iodine Def)20(icienc)14(y)65(. Un)]TJ
1.76563 -1.12501 TD
0.013 Tc
0.362 Tw
[(I)1(n)1(t)1(e)1(r)1(n)1(a)1(tional Challenge)1( )1(i)1(n)1( )1(N)1(u)1(t)1(r)1(ition. Oxfo)1(rd)1(:)]TJ
0 -1.125 TD
0 Tc
0.025 Tw
[(Oxford Uni)24(v)15(ersity Press; 1989.)]TJ
-1.76563 -2.25 TD
0.09 Tw
[(8.)-1016(WHO,)-340(ICCIDD,)-341(UNICEF)80(. Recommended Iodine)]TJ
1.76563 -1.125 TD
0.117 Tw
[(le)25(v)14(els in salt and guidelines for monitoring their)]TJ
T*
0.056 Tw
[(adequac)15(y and ef)25(fecti)25(v)14(eness. Gene)25(v)25(a:)-276(WHO/NUT)55(;)]TJ
T*
0.025 Tw
(1996.p. 96/13.)Tj
-1.76563 -2.24999 TD
0.042 Tw
[(9.)-1016(Ferreiro )55(Alaez L,)-292(Esconar del Re)15(y F)79(. 100 a\226os de)]TJ
1.76563 -1.125 TD
0.307 Tw
(literatura sobre el bocio end\216mico en Espa\226a.)Tj
T*
0.025 Tw
(Endocrinolog\222a 1987; 34(supl 2):4-14.)Tj
-1.76563 -2.25 TD
0.064 Tw
[(10.)-516(Marine D,)-314(Kimball OP)110(. )18(The pre)25(v)15(ention of simple)]TJ
1.76563 -1.125 TD
0.025 Tw
[(goitre. )55(Am J Med Sci. 1922; 163:634-6.)]TJ
-1.76563 -2.25 TD
-0.015 Tc
0.061 Tw
[(11.)-561(Garcia-Mayor R)80(V)129(,)-296(Rios M,)-297(Fluit)1(er)-1(s E,)-296(Mendez LF)80(,)]TJ
1.76563 -1.125 TD
-0.004 Tw
[(Garcia-Mayor EG)-1(,)-176(Andrade )55(A. Ef)24(f)1(ect of iodine sup-)]TJ
T*
0.197 Tw
[(plementation on a pediatr)-1(ic population with mild)]TJ
T*
0.025 Tw
[(iodine def)20(icienc)14(y)65(. )18(Th)5(yroid. 1999; 9(11):1089-93.)]TJ
-1.76563 -2.25 TD
0 Tc
0.173 Tw
[(12.)-516(Delg)5(ado E,)-423(D\222az-Cad\227rnig)5(a FJ,)-405(T)80(art\227n )17(T)74(,)-422(Bobis)]TJ
1.76563 -1.125 TD
-0.012 Tw
[(ML,)-188(V)110(ald\216s MM,)-238(MA. Erradicaci\227n de los trastor-)]TJ
T*
0.028 Tw
[(nos por def)20(iciencia de yodo en )54(Asturias (Espa\226a):)]TJ
T*
0.282 Tw
[(18 a\226os de yodoprof)19(ilaxis con sal. Endocrinol)]TJ
T*
0.025 Tw
[(Nutr)55(. 2004; 51(9):492-6.)]TJ
-1.76563 -2.25 TD
0.041 Tw
[(13.)-516(Serna C,)-291(Serra L,)-290(Gasc\227 E,)-291(MJ,)-291(Ribas L,)-291(Escobar)]TJ
1.76563 -1.125 TD
-0.017 Tw
[(del Re)15(y F)80(. Situaci\227n actual de la endemia de bocio)]TJ
T*
0.032 Tw
(end\216mico y del consumo de yodo en la poblaci\227n)Tj
T*
0.067 Tw
[(del Pirineo y de la comarca del Se)15(gri\210 de Lleida.)]TJ
T*
0.025 Tw
(Aten Prim. 1998; 22(10):66-76.)Tj
-1.76563 -2.25 TD
0.299 Tw
[(14.)-516(Santiago P)111(,)-549(Muela J)60(A,)-549(Delg)5(ado )55(A,)-549(Origuer F)79(,)]TJ
1.76563 -1.125 TD
0.1 Tw
[(T)80(orres R,)-350(S\207nchez C et al. Pre)25(v)25(alencia de d\216f)20(icit)]TJ
T*
0.002 Tw
(de y)Tj
1.69634 0 TD
(odo en la pr)Tj
4.75574 0 TD
(o)Tj
0.48511 0 TD
(vincia de J)Tj
4.28109 0 TD
(a\216n. Endocr)Tj
4.77762 0 TD
0 Tw
(inolo)Tj
2.05566 0 TD
0.002 Tw
(g\222a y)Tj
-18.05156 -1.12502 TD
0 Tw
(Nutr)Tj
1.83252 0 TD
0.025 Tw
(ici\227n. 2002;49[Supl 1]:)Tj
9.62945 0 TD
0 Tw
(77-8.)Tj
-13.2276 -2.25001 TD
(15.)Tj
1.76563 0 TD
0.132 Tw
(Madue\226o Car)Tj
5.60175 0 TD
(o)Tj
0.8266 0 TD
0 Tw
(AJ)Tj
1.11085 0 TD
(,)Tj
0.63153 0 TD
(Ca)Tj
1.11085 0 TD
0.132 Tw
(bezas Saur)Tj
4.43451 0 TD
-0.0001 Tc
(a)Tj
0.82537 0 Td
0 Tc
0 Tw
(PB)Tj
1.2229 0 TD
(,)Tj
0.63154 0 TD
0.132 Tw
(Diaz OJ)Tj
3.37982 0 TD
(,)Tj
-19.77572 -1.12504 TD
0.083 Tw
(Benitez RE,)Tj
5.24835 0 TD
(Ruiz GM,)Tj
4.41584 0 TD
0 Tw
(Gomez )Tj
3.16567 0 TD
0.083 Tw
(A. Pr)Tj
2.19376 0 TD
(e)Tj
0.41894 0 TD
(v)Tj
0.4751 0 TD
(alencia de)Tj
-15.91766 -1.12502 TD
0.075 Tw
(bocio y def)Tj
4.62886 0 TD
(iciencia de yodo en poblaci\227n escolar)Tj
-4.62886 -1.125 TD
0.33 Tw
(de una z)Tj
3.99108 0 TD
(ona b\207sica de salud tradicionalmente)Tj
-3.99108 -1.125 TD
0.025 Tw
[(end\216mica. )55(Aten Primar)-1(ia. 2001; 27(4):258-62.)]TJ
-1.76563 -2.25 TD
0 Tw
(16.)Tj
1.76563 0.00001 TD
(Ser)Tj
1.33252 0.00001 TD
0.145 Tw
[(ra-Prat M,)-395(Diaz E,)-345(V)111(erde )89(Y)129(,)-395(Gost J,)-395(Serra E,)]TJ
-1.33252 -1.12501 TD
0.025 Tw
(Puig DM. Pr)Tj
5.13235 0.00001 TD
[(e)25(v)25(alencia del d\216f)20(icit de yodo y f)9(acto-)]TJ
-5.13235 -1.12501 TD
(r)Tj
0.33276 0.00001 TD
0.16 Tw
(es asociados en escolares de 4 a\226os. Med Clin)Tj
-0.33276 -1.12501 TD
0 Tw
(\(Bar)Tj
1.77637 0.00001 TD
0.025 Tw
(c\). 2003; 120\(7\):246-9.)Tj
-3.542 -2.25001 TD
0 Tw
(17.)Tj
1.76563 0.00001 TD
-0.004 Tw
[(V)60(ila L,)-247(Castell C,)-217(W)80(engr)1(o)15(vicz S)-1(,)-246(de Lara N,)-247(Casa-)]TJ
0 -1.12501 TD
0.091 Tw
(mitjana R. Estudio de la y)Tj
10.84036 0.00001 TD
(oduria de la poblaci\227n)Tj
-10.8404 -1.125 TD
0.02 Tc
0 Tw
(ca)Tj
0.9277 0 TD
0.682 Tw
(talana adulta. Med Clin (Barc). 2006;)Tj
-0.9277 -1.125 TD
0 Tc
0 Tw
(127(19):730-3.)Tj
-1.7656 -2.25 TD
(18.)Tj
1.7656 0 TD
0.234 Tw
[(Peris RB,)-429(Atienzar HN,)-484(Mer)-1(c)1(hante )54(Alf)10(aro )54(AA,)]TJ
0 -1.125 TD
0 Tw
(Calv)Tj
1.8689 0 TD
(o)Tj
1.0177 0 Td
0.268 Tw
[(RF)80(,)-500(T)70(enias Burillo JM,)-518(Self)9(a MS et al.)]TJ
21.73936 66.37498 TD
0.138 Tw
[(Bocio end\216mico y d\216f)20(icit de yodo:\300sigue siendo)]TJ
0 -1.125 TD
0.037 Tw
[(una realidad en Espa\226a? )55(An Pediatr \(Bar)-1(c\). 2006;)]TJ
0 -1.12499 TD
0 Tw
(65(3):234-40.)Tj
-1.76563 -2.25 TD
0.011 Tw
[(19.)-516(Zubiaur )55(A,)-261(Zapico MD,)-261(Ruiz L,)-260(Sanguino )-1(L,)-260(S\207n-)]TJ
1.76563 -1.12501 TD
0.01 Tw
[(chez-Serrano FJ,)-205(Alf)9(a)1(yate R et al. Situaci\227n nutr)-1(i)1(-)]TJ
0 -1.125 TD
0.039 Tw
[(cional de yodo en la poblaci\227n escolar de )55(Alican-)]TJ
T*
0.025 Tw
[(te. )55(An Pedia)-1(tr (Barc). 2007; 66:260-6.)]TJ
-1.76563 -2.25 TD
-0.004 Tw
[(20.)-516(Barona-V)60(ilar C,)-246(Mas-Pons R,)-246(Fullana-Montoro )55(A.)]TJ
1.76563 -1.125 TD
0.012 Tw
(La tirotropinemia (TSH) neonatal como indicador)Tj
T*
0.286 Tw
(del estado nutricional de yodo en Castell\227n y)Tj
T*
0.046 Tw
[(V)111(alencia (2004-2006). Re)25(v Esp de Salud P\234blica.)]TJ
0 -1.12499 TD
0.025 Tw
(2008; 82:)Tj
-1.76563 -2.25 TD
0.224 Tw
[(21.)-516(Hetzel BS. )55(An o)15(v)15(er)-1(vie)25(w of the Pre)25(v)15(ention and)]TJ
1.76563 -1.125 TD
-0.021 Tw
[(Control of Iodine Def)20(icienc)14(y Disorders. In:)-229(Hetzel)]TJ
T*
-0.034 Tw
[(BS,)-216(Dunn JT)73(,)-216(Stanb)20(ury JB,)-217(editors. )18(The pre)25(v)15(ention)]TJ
T*
0.118 Tw
[(and control of iodine def)20(icienc)14(y disorders. )55(Ams-)]TJ
T*
0.025 Tw
[(terdam:)-275(Else)24(vier; 1987.p. 7-31.)]TJ
-1.76563 -2.25 TD
0.245 Tw
[(22.)-516(Diaz-Cad\227rnig)5(a FJ,)-495(Delg)5(ado-\347lv)25(ar)-1(ez E. D\216f)20(icit)]TJ
1.76563 -1.125 TD
0.019 Tw
[(de yodo en Espa\226a:)-269(Situaci\227n actual. Endocrionol)]TJ
T*
0.025 Tw
[(Nutr)55(. 2004; 51(1):14-25.)]TJ
-1.76563 -2.25 TD
0.126 Tw
[(23.)-516(Morreale dE,)-376(Obre)15(g\227n MJ,)-376(E)1(sco)-1(b)1(ar)-1( dR. Role of)]TJ
1.76563 -1.125 TD
0.06 Tw
[(th)5(yr)-1(oid hormone during early brain de)25(v)15(elopment.)]TJ
T*
0.025 Tw
(Eur J Endocrinol. 2004; 151 Suppl 3:U25-U37.)Tj
-1.76563 -2.25 TD
0.035 Tw
[(24.)-516(Delange F)80(. Optimal Iodine Nutrition during Pre)15(g-)]TJ
1.76563 -1.125 TD
0.187 Tw
[(nanc)15(y)65(,)-437(Lactation and the Neonatal Per)-1(iod. Int J)]TJ
T*
0.025 Tw
[(Endocrinol Metab)40(. 2004; 2:1-12.)]TJ
-1.76563 -2.25 TD
0.016 Tw
[(25.)-516(Dom\222nguez I,)-265(Re)24(virie)15(go S,)-266(Rojo-Martinez G,)-216(V)111(al)-1(-)]TJ
1.76563 -1.125 TD
0.154 Tw
[(d\216s MJ,)-404(Carrasco R,)-404(Coronas I et al. D\216f)19(icit de)]TJ
T*
-0.024 Tw
(yodo y funci\227n tiroidea en una poblaci\227n de muje-)Tj
T*
0.128 Tw
(res embarazadas sanas. Med Clin (Barc ). 2004;)Tj
T*
0 Tw
(122(12):449-53.)Tj
-1.76563 -2.25 TD
(26.)Tj
1.76563 0 TD
(Rodr)Tj
1.99975 0 TD
0.047 Tw
(iguez I,)Tj
3.34286 0 TD
(Luna R,)Tj
3.56625 0 TD
(R\222os M,)Tj
3.56722 0 TD
0 Tw
(Fluiter)Tj
2.66602 0 TD
-0.0001 Tc
(s)Tj
0.68612 0 Td
0 Tc
(E,)Tj
1.1582 0 TD
(P)Tj
0.54101 0 TD
(ar)Tj
0.77661 0 TD
(amo)Tj
-18.30405 -1.12503 TD
(C,)Tj
1.50714 0 TD
(Gar)Tj
1.49852 0 TD
(cia-Ma)Tj
2.83106 0 TD
(y)Tj
0.5 0 TD
0.34 Tw
(or R)Tj
2.01006 0 TD
(V)Tj
0.59301 0 TD
-0.0001 Tc
(.)Tj
0.8399 0 Td
0 Tc
0 Tw
(Def)Tj
1.479 0 TD
0.34 Tw
(iciencia de y)Tj
5.73302 0 TD
(odo en)Tj
-16.99172 -1.12503 TD
(m)Tj
0.77784 0 TD
0 Tw
(ujer)Tj
1.55443 0 TD
0.019 Tw
(es embar)Tj
3.59959 0 TD
(azadas y en edad f\216r)Tj
8.17938 0 TD
(til en una z)Tj
4.47064 0 TD
0 Tw
(ona)Tj
-18.58187 -1.12502 TD
0.231 Tw
(con ing)Tj
3.20239 0 TD
(esta nor)Tj
3.36794 0 TD
(mal de y)Tj
3.9048 0 TD
(odo. Med Clin \(Bar)Tj
8.52396 0 TD
0 Tw
(c\).)Tj
-18.9991 -1.12501 TD
0.025 Tw
(2002; 118(6):217-8.)Tj
-1.76563 -2.25 TD
-0.01 Tc
0 Tw
(27.)Tj
1.76563 0 TD
0.024 Tw
[(Gonzalez Mateo M,)-264(Fern\207ndez Fer)-1(n\207ndez M,)-264(Diez)]TJ
0 -1.125 TD
0.086 Tw
[(Hernandez )55(A,)-327(Delg)5(ado Gomez M,)-326(Garcia Men\216n-)]TJ
T*
0.031 Tw
[(dez L,)-271(Diaz Cad\227rnig)5(a F)79(. Bocio,)-270(funci\227n tir)-1(oidea y)]TJ
0 Tc
(e)'
0.41896 0.00001 TD
-0.01 Tc
0 Tw
(xcr)Tj
1.24662 0.00001 TD
0.003 Tw
[(eci\227n de yodo en gestantes de la zona del Bier)-1(-)]TJ
-1.66558 -1.12501 TD
0 Tc
(z)Tj
0.43385 0.00001 TD
-0.01 Tc
0.025 Tw
[(o. Endocrionol Nutr)55(. 2002; 49(9):289-92.)]TJ
-2.19948 -2.25001 TD
0 Tc
0 Tw
(28.)Tj
1.76563 0.00001 TD
0.006 Tw
[(Almod\227v)25(ar F)80(,)-257(Gor)18(gojo J,)-257(Lahera M,)-256(Ca)19(v)25(a F)80(,)-207(V)111(alor)]TJ
0 -1.12501 TD
(S)Tj
0.55591 0.00001 TD
0.003 Tw
[(,)-253(Donnay S. D\216f)20(icit de yodo en una poblaci\227n de)]TJ
-0.55591 -1.12501 TD
(m)Tj
0.77784 0.00001 TD
-0.012 Tw
[(ujeres embarazadas pertenecientes a un \207r)-1(ea con)]TJ
-0.77784 -1.12501 TD
0 Tw
(le)Tj
0.69677 0.00001 TD
0.015 Tw
[(v)15(e def)20(iciencia de y)-1(odo. Endocrionol Nutr)55(. 2006;)]TJ
-0.69677 -1.12501 TD
0 Tw
(53(10):577-81.)Tj
-1.76563 -2.25 TD
(29.)Tj
1.76563 0.00001 TD
0.156 Tw
[(Bonet-Manso MP)111(,)-406(Bel\216n )55(Ati\216nzar MB)-1(,)-406(Fuentes-)]TJ
0 -1.12501 TD
0.08 Tw
(G\227mez MI,)Tj
5.01826 0.00001 TD
[(Plaza )50(V)60(icente C. Concentr)-1(aciones de)]TJ
-5.01826 -1.12501 TD
(y)Tj
0.5 0.00001 TD
0.171 Tw
(odo y su ingesta en una poblaci\227n de mujeres)Tj
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
6 0 0 6 63.7795 647.7751 Tm
0 Tr
0 0 0 1 k
0 Tc
-0.025 Tw
[(Ll. V)60(ila)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
8 0 0 8 63.7795 53.9363 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(376)-27412(Re)25(v Esp Salud P\234blica 2008,)-225(V)128(ol. 82,)-275(N)1<2EA1>-275(4)]TJ
ET
Q

endstream
endobj
11 0 obj
<<
/Length 4920
>>
stream
/GS0 gs
q
0 0.654 498 691 re
W n
1 g
0 691.654 0 0 re
f
Q
/GS1 gs
/GS2 gs
q
BT
/F0 1 Tf
8 0 0 8 77.9045 609.5268 Tm
0 Tr
0 0 0 1 k
0.016 Tc
0.359 Tw
[(e)1(m)1(b)1(a)1(r)1(azadas sanas. Enfe)1(rmer Cl\222n 2007; 17)]TJ
0 -1.125 TD
0 Tc
0 Tw
((6):293-301.)Tj
-1.76563 -2.24999 TD
0.167 Tw
[(30.)-516(Grupo para el estudio de la D)55(Y de la Sociedad)]TJ
1.76563 -1.125 TD
0.048 Tw
[(Galle)15(g)5(a de Endocrinolo)-1(g\222a y Nutrici\227n. Def)20(icien-)]TJ
0 -1.12501 TD
0.06 Tw
(cia de yodo en gestantes de la Comunidad Galle-)Tj
0 -1.125 TD
0.025 Tw
[(g)5(a. Endocrinolog\222a 2001; 48\(Supl,)-275(2\):62.)]TJ
-1.76563 -2.25 TD
0.036 Tw
[(31.)-516(Garcia-Delg)5(ado C,)-286(Delg)4(ado E,)-286(D\222az-Cadornica F)80(,)]TJ
1.76563 -1.125 TD
0.149 Tw
[(\347lv)25(ar)-1(ez J)60(A,)-350(V)111(ald\216s M,)-399(M\216ndez )55(A et al. Estudio)]TJ
T*
0.117 Tw
[(sobre nutrici\227n de yodo en embar)-1(azadas asturia-)]TJ
T*
0.025 Tw
[(nas. Endocrionol Nutr)55(. 2003 50[Supl 2]:5-6.)]TJ
-1.76563 -2.24999 TD
-0.01 Tc
-0.03 Tw
[(32.)-546(Men\216ndez E,)-210(Larra\226ag)5(a C,)-210(F)15(or)18(g)5(a L,)-210(Roche M,)-210(Rico)]TJ
1.76563 -1.125 TD
0.271 Tw
[(B,)-511(Go\226i MJ. Estudio del estado nutricional del)]TJ
T*
0.038 Tw
[(yodo en mujeres embar)-1(azadas del \207rea sanitaria de)]TJ
T*
0.025 Tw
[(P)15(amplona. Endocrionol Nutr)55(. 2006. 53:)-265(124-5.)]TJ
-1.76563 -2.25 TD
0 Tc
0.065 Tw
[(33.)-516(Martull P)111(,)-315(Casta\226o L,)-260(Agua)-1(yo )55(A,)-315(Grau G,)-315(Rica I,)]TJ
1.76563 -1.125 TD
0.124 Tw
[(V)111(ela )55(A. Indicaciones del tratamiento con yodo a)]TJ
T*
0.329 Tw
(las embarazadas. Situaci\227n de Bizkaia. Bol S)Tj
T*
0.025 Tw
[(V)111(asco-Na)20(v Pedia)-1(tr)55(. 2007; 39:16-21.)]TJ
-1.76563 -2.25 TD
0.133 Tw
[(34.)-516(WHO,)-383(ICCIDD,)-383(UNICEF)79(. )55(Assessment of iodine)]TJ
1.76563 -1.125 TD
-0.014 Tw
[(def)20(icienc)14(y disorders and monitoring their elimina-)]TJ
T*
0.251 Tw
[(tion. )55(A Guide for programme manager)-1(s. 2007.)]TJ
T*
0.237 Tw
[(Disponible en:)-487(http://whqlibdoc.who.int/publica)-1(-)]TJ
T*
0.025 Tw
(tions/2007/9789241595827_eng.pdf [Thirst].)Tj
-1.76563 -2.25 TD
-0.012 Tw
[(35.)-516(Donnay S,)-238(Fern\207ndez )54(A,)-183(Abel M,)-239(Escobar del Re)15(y)]TJ
1.76563 -1.125 TD
0.19 Tw
[(F)80(. Disponibilidad de sal yodada y su contenido)]TJ
T*
0.025 Tw
[(real de yodo. Endocrinol Nutr)55(. 1999; 46:224-7.)]TJ
22.86036 34.875 TD
0.207 Tw
[(36.)-516(Santiago MI,)-456(Fer)-1(n\207ndez S,)-456(R\222os M,)-457(Fluiters E,)]TJ
1.76563 -1.125 TD
-0.033 Tw
[(Herv)25(ada X,)-217(Iglesias )17(T)74(. Excreci\227n Urinaria de )90(Y)110(odo)]TJ
0 -1.12499 TD
0.122 Tw
(en escolares de Galicia. Endocrinolog\222a y Nutri-)Tj
0 -1.125 TD
0.025 Tw
(ci\227n 2005; 52(9):498-501.)Tj
-1.76563 -2.25001 TD
0.289 Tw
[(37.)-516(Soriguer F)80(,)-539(Millon MC,)-540(Munoz R,)-539(Mancha I,)]TJ
1.76563 -1.125 TD
0.138 Tw
[(Lopez Siguero JP)111(,)-388(Mar)-1(tinez )55(Aedo MJ et al. )18(The)]TJ
T*
0.163 Tw
(auditory threshold in a school-age population is)Tj
T*
0.364 Tw
[(related to iodine intak)10(e and th)4(yroid function.)]TJ
T*
0.025 Tw
[(Th)5(yroid. 2000; 10(11):991-9.)]TJ
-1.76563 -2.25 TD
0 Tw
[(38.)-516(Moll G,)-200(V)60(ich F)80(,)-250(Nicola G,)-250(Frontera B,)-250(Frontera G,)]TJ
1.76563 -1.125 TD
0.022 Tw
[(Llad\227 I et al. Pre)25(v)25(alencia de Bocio y estado nutri-)]TJ
0 -1.12499 TD
-0.002 Tw
(cional de yodo en un grupo de escolares de 8 a\226os)Tj
0 -1.125 TD
0.37 Tw
[(de P)15(alma de Mallorca. Endocrinolog\222a. 2006)-1(;)]TJ
T*
0 Tw
(53:132.)Tj
-1.76563 -2.25 TD
0.099 Tw
[(39.)-516(Re)15(go-Iraeta )55(A,)-349(Per)-1(ez-Fdez R,)-349(Cadarso-Suarez C,)]TJ
1.76563 -1.125 TD
0.136 Tw
[(T)80(ome M,)-386(Fdez-Marino )55(A,)-386(Ma)-1(to J)60(A et al. Iodine)]TJ
T*
0.02 Tc
0.371 Tw
(nutrition in the adult population of Galicia)Tj
T*
0 Tc
0.025 Tw
[((Spain). )18(Th)5(yroid)-1(. 2007; 17(2):161-167.)]TJ
-1.76563 -2.25 TD
-0.027 Tw
[(40.)-516(De Santiago J,)-222(P)15(astor J)-1(,)-222(Escobar del Re)15(y F)79(,)-222(Morre-)]TJ
1.76563 -1.125 TD
0.08 Tw
[(ale de Escobar G. Def)20(iciencia de y)-1(odo y funci\227n)]TJ
T*
0.074 Tw
[(tiroidea en la embarazada. Endocr)-1(in)1(olo)-1(g\222a. 1999.)]TJ
T*
0.025 Tw
[(46; [Supl 1]:)-275(7.)]TJ
-1.76563 -2.25 TD
0.004 Tw
[(41.)-516(Soriguer F)80(,)-254(Garcia-Fuentes E,)-254(Rojo G,)-254(Santiago P)110(,)]TJ
1.76563 -1.125 TD
0.215 Tw
[(Olv)15(eir)-1(a G,)-465(Garrig)5(a MJ et al. Protocolo para el)]TJ
T*
0.351 Tw
[(estudio de trastornos debidos a la def)19(iciencia)]TJ
T*
0.017 Tc
0.358 Tw
[(nutricional de yodo. Endocrinol Nutr)55(. 2005;)]TJ
T*
0 Tc
0 Tw
(52(3):105-24.)Tj
-26.3916 -34.5738 TD
0.025 Tw
[(Re)25(v Esp Salud P\234blica 2008,)-226(V)129(ol. 82,)-275(N.\241)-274(4)-27412(377)]TJ
ET
Q
/GS3 gs
/GS2 gs
q
BT
/F0 1 Tf
6 0 0 6 241.3652 647.7751 Tm
0 Tr
0 0 0 1 k
0 Tc
0.025 Tw
[(PREVENCI\356N )90(Y CONTR)39(OL DE LA DEFICIENCIA DE )90(Y)30(ODO EN ESP)92(A\204A)]TJ
ET
Q

endstream
endobj
12 0 obj
<<
/Length 66
>>
stream
/GS0 gs
q
0 0.654 498 691 re
W n
1 g
0 691.654 0 0 re
f
Q
/GS1 gs

endstream
endobj
13 0 obj
<<
/Nums[0<</St 371/S/D>>]
>>
endobj
14 0 obj
<<
/BaseEncoding/MacRomanEncoding
/Type/Encoding
/Differences[32/space 37/percent 40/parenleft/parenright 44/comma/hyphen/period/slash/zero/one/two/three/four/five/six/seven/eight/nine/colon/semicolon 63/question/at/A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P 82/R/S/T/U/V/W/X/Y/Z/bracketleft 93/bracketright 95/underscore 97/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y/z 132/Ntilde 135/aacute/agrave 142/eacute 146/iacute 150/ntilde/oacute 156/uacute 161/degree 181/mu 187/ordfeminine 192/questiondown 231/Aacute 234/Iacute 238/Oacute]
>>
endobj
15 0 obj
<<
/Subtype/Type1C
/Length 10139
/Length1 10139
>>
stream
  KIFCEI+Times-Roman   @¯ ¯¯¯¯˚<˚n˙|˙
 ãã
 ãã      œª  'k ö•™001.007Copyright (c) 1985, 1987, 1989, 1990 Adobe Systems Incorporated.  All Rights Reserved.Times is a trademark of Linotype AG and/or its subsidiaries.Times RomanTimes  Z  4 F H ﬁ O  M B 0 .  J W N V E G  D Z P 	 % : 
 T Q S C » U ◊  ) I R ” ÿ 1 œ  5 Y  - " 3 & 7 / $ * ª '   ò      K [ ( ;  6    ° + # ! ∫  ã {   ∂ 8 X @ < > L , À ´ 9 \   m Ωí'ôú›j∫(eø¡*∞˛iÂ-g 	1	k	
o
—7=˘É˛t‹R¬Ay«LûÈQÃKûˇ\íÜÎ7¶k›ü‡CâGxÿ]∑Ù/v¬pãë 
 o ¸!å!°! !Û"Ç"¸#µ$P$‡¸$-}Ø¯˘¥“·˜}¯S˘8vÄâÜtorU≠O10S˚(À_ÁV˜'5õiRUcR;˚X˜∫xt©˚h°õïú†©ºiã◊˜#œÎ‡˜a˚‚üã˜*…æ™ΩÙÀ19ú§˚bÅ–˜n´˜Ø§–¯,˜8ft`G2I:¥˜E˜À˜ÄDø-;˚N˚M˚"◊9˜˜$≈˜™ï˚€˜,„õ≤¶¬⁄ïH[í˚*˚nƒ˜&◊av˜+§˜j≤êßß—nﬁ<«˜Xÿ¶ß∂ Ì1©ù†™∞’ ∫Å°ãÈà’âºâã^ãVG_˚	ã∂ ˚g≥™’`¡¯DŒ≤¢Ø·õ˚ouÜAG=q‰⁄› ˜“π≤>{yçìv’ öcuìh?+[˚Q≠]∆q‘†2<ã~zo•¶~÷ Xg\b^V÷_ÒÂ˜:√˜ß}’ ê‹‡˚ëmå[éã¢ü≥¥üçëØÜãó√Ú≤˜ ΩÇûÅ¢˚*Å≈ô¯ôƒ˜?“ﬂ°˜tGﬂﬂ˜¯è˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(˚E¸èj¯sΩOââ¢Ø˜Î˚2z—âèvc™˚jÑÅÇÉupm}mIÇ…ô˜⁄˚&}©â´âO˚ê!Ÿs¥ùªè≤≤∂∂8çâj∫ú±ô¡ô˚*ãö¯òÅ¬€ﬂ˜Dﬂ∏€ÂP|~\à|˜höWé}õ¨˜≠∞±™ü©∆ùgN˚e?qÜfà|˜döZèö∫˜y˜D¶]Peh]Z⁄Ñçÿ]z\|^~zçèñçôõûäL¸$¸ãö¯ˆô∑wÌﬂ∞†˜ÄöQézì≈¯ÈáçVzV}V~{åóîåò≤ë{^¸qTy~Pá˚bÅƒ˜Üv˜<£∞„Fﬁ˜(‹Ù˜≥˜màl|ÜÇl~ufn™∫ç≠ñ√˜+Ω˜/˚^ÇÄ~Åvnã®®˜W«ãÔ˚)Ï˚\Dc{óo™•û°†îÜöãö™±ù¨©∫ÄCNÙ˚7K4i'Høf¡¬¿≥¨∞Cêµäùõ™åºµ”}Ø¯˛Ø≠˜¯>˜˜˝}˜I˜&˜˜i˜z˚7˜˚8˚8˚7˚˚z˚i˜&˚˜IØ˚%‰˜p˜x˜‹ÒÒ˜:˚x˚p%2˚˜Éãû˘û˜∑¯ùÒ˘Û˘*˚[˚q¸ç˚{¯ç˚Zx’á†É=¸*˚ v|?Üx˜ûBév°Ú¯#ç˜ç¸∂ô˜í¯Õç¸U9~|=áx˜¨ûKètîÿ¯P⁄£ë ê¸$Ö˜ 8v˜0≤†ﬁ˚!©ï›Õ“ﬁQòtrj|`cØÅ•íêååéåèéåç`ííÜÇx{^Ia¸ãö¯ñ¬w˜!ÒŸÒ6ﬂÙõ˜ÅöFèÜúÕ˜˜áéWxXxWz|çòòçôõûäP˚|=zÖMà…¯˝xôkØ©°°®ßu¢mh|kx˚*ív¯Uöû¯^¯q¯V˚|§ä°ÇtgD˚0i+%˜îàìÖöãó§°é£çö˚X|üäüÖömØDÎ˚|£Mõ`çáîãíãî¢ñ¶˜˜’£∆íõ≠é˜ãö¯òÑø·ﬂ˜Lﬂ˜Lﬂº·‡Hmâcä|˜röhåjçº˜Æêπ¡–øúdI˚mJtà^à|˜töbålé◊˜ê≠°≠¶¬”åPX˚gK{âYÖ|˜oöqç_íå©ã°˜b’}Û#<NOsvµÄlµJUbk^P÷Ñç‹]z\|\~zçìïçôõûäL˚*Å≈ô¯ô“ﬂ˜Fﬂx¯sΩOââ¢Ø˜Î˚2z—âèvc∏˚jÑÅÇÉupm}mIÇ…ô˜⁄˚&}©â´âO˚ê!Ÿs¥ùªè≤≤∂∂8çâx∫ú±ô¡ô˚*Åøãõ¯
ß˜8ö∑w¶·˜wﬂÆ˜ËÒgÉdsaIC√˜)˜œº√∫ºkGín˜+˚¶HÜãü¥¯ÀÜçæ[zZ}Y~{åìïãë∑ãvm˚0®jmô`˚,˚˚˚`˜#w≤’∞∞¶ùçNèàn¿ûπõªú˚—ãö¯'´˜aßÚﬂ˜…¯V˚˜∞êø¬∫ê@ãµü¢ò®≠_¶S˚Hã˚ES9k›˚Œ>zÇIà|˜òö/çä•»˜Œ˜˚—†v˜V ≤˜ä≤˜ïL˜ä ˚bÅ”¯®§ÿ¯"˜0Xif`C7F◊˜˜'Á™∞¿êymìëuëuúq•ç©çõû¢ù~™m†õr^ög˚ ˚8˚8˚2ˆJ€‹Ã∂˜¡˚*˚nﬂ7Ò¯ªöô¯a∞¯o¯V˚|´åõÅxÇ~kÅp=˚r˚˜ëàíÑõãò¶Æå¢åö˚b}òâ•Üór˜˚äôlª/|{c˚Wp~lùãp]âeÖ∞q¢kΩ÷∑Õ˜æ˜.¯,ö¥üçòç˚*Åß¯2ß®Â˜ôÂ˜â¯`˚9˚˚˚Â$˜˜,—˜Ó˜%-‚˚ú¸N˚t˜L’Û¬ø Áæ˚˚˚#HeX˚—†v˘8wª·˜ª˘8˚///˚*˚@˚¨CºC±SÕE≈lóõ˚>˜ã˜oÒ˜íÎŸ’∆”ãûx∞¯‡∞xûÛÒ¯˜lõ˜∞˜∆⁄˜X˜˜t˚3˜˚Ñ˚¢úxÿÖñÅA¸PE{?ál˜R¯Àüãû∫˜√p`ª–M£:7˚∑˚äãK[í≠”ãû˘û˜œÒ˘S˘*˚ox™±âl}ÑÑÄ˚#˚v˚(˜rÇòÉûãñß§åπçû˚¨x∏áöàÒ˚*˜˚T˚B?àt)âx˜∆û1å~ú”˜V˜(˜v–ı¨èØè˚—†v˘8w˜[·±˚E˜/ÁÁ˜*˜@˜j”Z”e√I—Q™{˜>˚ã˚o%˚í+=AP˚ôÅ°êv¯[wë¢æ…Nò˜i—[ò•˜œ˜Œá˜ÄôáàÜÑÇzlü_*`ISA¬f…hñ≈j´yüsãkR\{i)x‚¿{U˚0òñîëèéóåß∂x∏À‹µ‚«hßZ©ô˚ Àf°Ö®ãü•†≤¬∑∏v%°˚*˚mù˜Q´¯öÇ«÷ﬂ˜u·‹÷˚`ávIÜz˜ÜùC{ñÀ˜1k¨ßÄ≥˜“˜ ˜˜?›2>]Zovâç‘ÖçÏ[x[z[|{åîïãîÆézc‹ﬂà±ë√ßØ˜ê˚6t˚B1xjT\∂¢˚—ãö˜ÔÌIóÇ ◊ﬂ»◊ﬂS{àTÅ|˜ÑöXçiè–ò˜u´∑Ω£»£ïhãÆ£ôû§¨w†ieiwD\â‰Üç®ZwYyZ{{çîñçôõûäP˚*Å´¯ ˜8ö∑w–ﬂ˜w„‹˜-˜÷ƒèÀù´ÊØ$.I{˚˚rDòÆ7{fÙpΩ˜M∆˜2ÂˆR˜˚?VQtÖâ˜¬Üç¸[zZ}[~{åëïãë∑ãvm˚bÅƒ˜Üv˜<£∫˜?∞„Fﬁï˜t5‹√˜¯è˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(˚)¸èÈ˜≥˜màl|ÜÇl~ufn™∫ç≠ñ√˜+Ω˜/˚^ÇÄ~Åvnã®®˜W«ãÔ˚)Â˚\Dc{óo™•û°†îÜöãö™±ù¨©∫ÄCNÈ˚7K4i'Høf¡¬¿≥¨∞Cêµäùõ™åºµ¸Åø¯´—ﬂ˜ì¯V&˜ìãêÑfV|ueduuuÖããàçàçä¿˚¡'¥pæπ∫¨∂£~ñÄ~yukãXã∆™˜≤˚*ãö¯òÅ¬”ı€ﬂ<˜ﬁ@ﬂﬂ˜¬˘cz}Åp|vîësótóuëvãHmR_É®úëñ®±óòÜÖó¢Ä®}†Å™ãŸù”≠î¸3˝™€ÂP|~\à|˜höWé}õ¨˜≠∞±™ü©∆ùgN˚e?qÜfà|˜döZèö∫˜y˜D¶]Peh]Z⁄Ñç ]z\|^~zçèñçôõûäL¸$Ä˜—˜˜Ä†Æú∞™q•mmrrke≠{†”ãû˜º∑˜∞ûˆÒ˜√Òû˜™û=êÅûÕ˜b˜√˚W@áu7áx˜™û=êÅûÕ¯P“óò◊ëû˚™x’ÖôÅA˚V˚√˜V“óò◊ëû˚™x’ÖôÅA¸E@áu7á˚*ãö¯¡˜8ö∑w‘ﬂ˜Nﬂ‹¯{öYîÅê‘˜[≥ä˜˚OZkYhâ˜¬Üé¸[zZ}^~{åéïãë∑ãvm¸kBÅÑUÑ|˜löZêxêÿ˜Öª¥≤ö®¬°dH˚Z>xÜZÜ|˜h˚*˚mú˜R»¯ßáw£·˜{ﬂÏ˜¸¯=°dtòX˚)˚˚˚+÷D‰»—µ©úê˚NY}t@àz˜Äô^ïyèª‹¯ÈáèÑàB˚ﬁäkã{WxyÑzâ|ã2ãdÍãÁÏ˜¡‘‹ÍåDo¸ãö¯ñ¬wŒ˜?Õ˜t˚Wﬂp˜¯è˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(I¸è‰õ˜ÅöFèÜúÕ˜˜áé˚/T|çòòçôõûäP˚|=zÖMà˚*Åß¯2ß∫˜?®Â≈˜tvÂﬂ(˜¯è˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(˚E¸è‘˜â¯`˚9˚˚˚Â$˜˜,—˜Ó˜%-‚˚ú¸N˚t˜L’Û¬ø Áæ˚˚˚#HeX-ãû˜°≥˜Ω∞xûÔÒ˜{˜‹õ˘‘ÑñD¸ECãt7Öx˜¨û>çzö‘˜Jâ£ûä£ÙÀù¥∂úõ∑¥ŸÏ˜˚¿˚˚ú˜ND¨ñå©∑˜&â˚#˚,˚ãfvwåçx˚bÅ–˜n´˜Ø∫˜?§–¬˜t√˜¯è˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(˚)¸èË¯,˜8ft`G2I:¥˜E˜À˜ÄDø-;˚N˚M˚"◊9˜˜$≈˜™ï˚€˜,„õ≤¶¬⁄ïH[í˚*ãö˘)w˜i·˜
˜®ö@wñª¯ÏÉç˚H0}°√ããó≠ãqv¸YAfâQâdãû¯Ìµ¥v˜~Ò˜~v8¯Xû7éûœ¯ì¡˜ßy˚†£Ö˜>¸»Ö˚>£˜°¶û˜¡¸àAàt0áx˜∏˚*ãö˜©v˜8öú¯b˜¬‘èÜó|vÇálä|˜]özåpåe≈˚˜Xﬁ˜ìò©©∂åö˚2|úä¢ävÄÖÇN3x®b»ù†§çùö˚c|¨åóã¥NÈ˚$˚˚9k]}âpà|˜%özvãùâñô†ëî⁄˜˚*ã◊¯¢’˜Ê·¯o˜~êdLxàfã˚É˜<˜D∑∫ﬂÊãı˜1œ03-[˚+m†Ü°¡©◊Êã˜
§/X@`14.˚F˚Q¯dãûx≤¯ûÓÒp˜∫˘*˚Æx Ü£Ö<∞¸P>tÇKápx¯Æª˜Br˚RKá˚*8yå≥¯m⁄§íœè”ãû˜Y¥¯5wö˘G˘Vû_é}ñk‘˚ç¯Ãw˚d¸x_lBtryxzâ{äx˜Zûv\ãµñéôêòπ˜	˜ö¥+ë}òjã{fjäfx˜ì¸~˜ï˜˜ß˜˚ßúãû˜¥Ø˜Æ∞xûÒÒ˜~˜Ï˘'ûbçsùu¶˚b˜ëæï˜£˜˜.˚9†2˚®‹x—ÑöÇA¸E@áv:Üx˜©û;èÅûŒ˜Y√ç˜Ç˚»˜5Ï¸[¯·®îí¿¥˜à˚˚#˚*â7ädãûx±˜µ¥˜î±xûÓÒ˜ú¢¨ˇ Ä w¯È˜=o&_Ym˚˚)ãå¥˜å˜.âﬁäö}ó;¢˜|tDÄÅs2˚.˜r≠óã†˜˜•{2ö§à˜#¸ßØx Ü£Ö<¸P>tÇKáwx¯∞”ïv˘"ûõ˘=˘M˘*˚ax±âÆàbvzaâÖ˚'¸˚+˜Êtæy¥ãö´ûç√éû˚ûx∫âù¥0˜ä¸πö˜r¯≈©◊ôôªé”ïvñû˘û˜∑¯3∑x˘W˘*˚xœÜßÉ˚˚‚â¸¯u˚?x≥õÜY¥¸M˚ v|?Üx˜ûBév°Ú¯ç∏¯L¸∏ú¯¢˜	´è íú}∑¯Ú≥ß˜˘ ¯WÇ˜uvjÉjãÜuJ¨2˚@˚<˚˚t˚ç˜A+˜5˜L·˜çåyùlmCD˚ã˚˚‚˜h˜$∑À≤±¥µ≈üΩ˜”;"§˚—ãû˘û˜Òù˜ΩûAçsïŸ¯P€§í‘éû˚ΩxﬁáôA¸PDz6â”}Ø¯˛Ø∂˜?≠˜˜ ˜t…˜˜W˜h(˜¯è˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(˚¥˝c‘˜˝}˜I˜&˜˜i˜z˚7˜˚8˚8˚7˚˚z˚i˜&˚˜IØ˚%‰˜p˜x˜‹ÒÒ˜:˚x˚p%2˚-ãû˜»¥˜î±xûÓÒ˜ì¢µˇ Ä Ó¯s˜{˜|t@Åyw9˚%˜r©íè§˜˜•{2ö§à˜#¸ßﬁx Ü£Ö<¸E9|@áx˜¨ûDéwó÷˜o˜%â÷ä£Åñ7˚*ûv˜É∂¯ß©Á˜ÑÏ∆u˜íõ˜&˜R˜h˜;+˜˚˚;˚ ˚9π˚˜Ω¿ù∞∑çâÖrT˚w˚Üc˜∆˜˘yà~Åzvayj!u˜	◊›¢Ëﬂ˜ã˚WP˚*}•˘•£Î˜òÎ˜é˘˜ç˚èG<â˚Ñ˚˚â˜Ç‹œç˜è˜•˚La˚w˚
˚µ˚t˜L˜Lµ˜t˜˜
a˜w˚L˚*˚Yv˜d∞f…¯"w«„˜V„º¯B¯V3˚„r`eXOo±¡˜∆3¸ MsFãO\ïiØØï≠∫«m–ÖÕçç´O¡Å™ãæøØæ®çbú]øØßï∫≠ì‹wv}É|kãµ¢˚*}ß¯π˜Ñõ≠Ë˜èÂ¯R˘@˚ÜÉ˚>˚J˚_˚fÒ,˜
˜FØ˜3‘˜=◊!SvjTû˜Ó˜˜Fß˚b˚≤ı©'$˚]WL@H’˜<«ï£ïï£§Øì≠˚*}∞¯ƒ⁄˜¯—˜I¯€˜Xñîãîé±‰ÇíÄ|ÇÄqã˚e˚˚ÅàÑéÖëã˜ á˜E\˚4˚ASJUp…ãKcãnÅg∫s⁄˜2˜ı˜‰Ä®`øP”-ú;ô˚*}Ø¯Ê«˜“⁄e”–˜-˜ﬁ–ç§ÜØxÀjóAãrã@b<.ãPãe√]ã{ãtÑãoãW‚Ü£ã˜1ã˜„ã˜"ã˜6Æaù‡Õ∂¶∂¡¥pÈ˚H2l˚cöáößµŸÊã’ØVX/@[0n˜Kã©˜ó≠õ´˜h§£©»◊˜r§Ã◊˜q•∑Ä˘+¯˚#˚!F©GË˜⁄˜*˜ÚBíg∑Äòk≥©gZ6E˚4Kã√üµ¡˜SÏ∑Äa˜Âdmkbe7Wyôò{ˇÄô{}ò]˚
*˚'&”h∏˜ÿ˜/Û∑Ä†àïáôÖöóá≤¡ßöò¢çâ˚Ò˝ªˇÄY˜‰dtû¬ﬁŸ˜,Õû~{{ ëxéÄz˚;˚
;˚*ã˜{KÀ¯Qwó≥˜ÑŸx¯l˜{%¯Q_˚Œ¸QK˜≠∏˚;ÿx˜;Ò˚HÀ˚Ñ˜Ç˜Ëç¸˚n≠¯÷ó¡w˜!ÒÁÒ6ﬂÙ˜^9ãRYgÅ«ã`xv|tfπx∫˜¥˜	¯]ÜéWwWyW{{çöòçôõûäPz˜æxôkØ©°°®ßu¢mh|kx˚bã©¯©ˇ 6Ä ˇ Ä ¯6˜yè{=Öl!ã˚˜°¯)ö˚Ôà˚
ù¡íè≠‘˜˚û¸)|¯”}≥˜ ù˜Æ≥´˜¯ Ïd•¯˘Y˜ˆ˚ìyœÜüä8˚6gFtG˚/#˜˜I˜ë˜' ÍÙ˜ ø(C¶¢É˜guoÖjÜÉk]¨&˚h˚˚;˚<˚©P¿Q>“˜mÓ¯˜˜≈ô˜]“•ç∑èdã±¯ﬁ±î¯‡¯“˜DBuxJ˚˚ï¯D¯ıö¸¢w˚?•ŒòóÕ˜#˜q¸I¸ı|¯»£˜D˚*òv¯Ë’ü¯A¯U˘*¸{_`$úÉ¨øù®Ãã˜m˚Z¸ËÃ˜h˘"”}∑¯˘ûÛÒ˜˝∑˘U˘*˚|x—á£z ˚¢:Åj~u\nRk=˚Bã˜À˜‘“óò⁄ëû˚Øx◊ÜôÄA˚ÃOã˚W˜å˜óã˜P€˜ôÙúöÿì˚*}ß˘ß√◊E’˜o–T◊‰˜h˜Ã˜9µmAE\aL:]ÃÿËÊª≤´•˚0˚:=Õ9˜‰˜:¨˜øŒv≈˚Îÿ¡®€µÁ◊MÕ˚5&U&:≥iﬂAË2Gbl4ÿ€¯%ª´¿÷ÿÆUT3Sferg¢2ƒŸ¸Ö˜ 8v˜Ú˜‹˜≤®ˆ˚!¨ó⁄Ã—ﬂPóvÄ[àTf©~´íêååéåèéåçhííÜÇx{^Ia0±¯j†Æú∞™q•mmrrke≠{†¸Ä˜˜å˜‹˜`˜˜†Æú∞™q•mmrrke≠{††˚˚†Æú∞™q•mmrrke≠{†˚é†v¯≠˜n≠ƒ≤˜d≤˜\¯<Q]æ≈≈πæ≈≈πXQQ]XQi€  €€L ;;LL;; L€˚ô}±¯ˇû˜DÒ˜™¯Ω’ôñŸêû˚≥x‹Üó}D¸cW|}se§ﬂãGnzmx}ë{õyñ§~µ¶˜!é˜Vúãûx∞˜µ≥˜ó∞xû˜Ò˜ÜÒ:˜Æú˘›áôA¸PDz7âx˜‚≠˜rü˜±Ù;ª4ùçÆ∏ñ„°˜˜/˚Cô4˚¨˜Z˚‰Î´ÜÅ≠uø{ºj9˚˚ÇIQyè∞¯ôöçôüïôåã†∂“Ûx˚˚˚âo,ä˜£}≤˜
¨k∂˜©∑˜™˜ﬂ˜“¯≥ø¯–¯#˚!~MDaho£«˜‰”ªﬂ©òta˜˚⁄qRWu2˚B˚˜˜#˜r˜˜
˜-˜KÙ˚+˚5Z˚
:^ëºöéÃ˜íFÅe~£ß]ã˚M˚>Eø˚œßå≈ëππñùçﬂ~ä£QÕ˜Œ˜Ò˜=˚$˜˚L˚Z˚;˚%˚l˚˜˚W˜ôŸœß® ”ïvñû˘û›ı˜∑∂˜ﬁµ∑˜W˜h˜¬˘cz}Åp|vîësótóuëvãHmR_É®úëñ®±óòÜÖó¢Ä®}†Å™ãŸù”≠î¸¢˝Êj˘W˘*˚xœÜßÉ˚˚‚â¸¯u˚?x≥õÜY¥¸M˚ v|?Üx˜ûBév°Ú¯ç™¯L¸∏ú¯¢˜	´è í¸ív˘FwÇ˜º˜≥˘8H˚y˝Fœ¸
†v¯Øg∫˜cßè X«›“∫˜2¯näÖãÑÅÇÖàwÉ}ãsã{ùã®ãû¢°œ°÷˜˚ÖÑÇÖ~ãó¢˜¨Ñ *@ihk}ñzüüóòòèàîãîñ§ñ†¢ózrm∫-iPvO^∞uÆÆÆ£üü⁄_í¶ãóñüå®¶˚b˚n©¯πÙ©Á´˜ Mú˜ æ¨˜\˜∫}5qcTKmh^EãXãWît¶j£nÕnƒã–ãÈ∂ãã≠Å®cãoãÄsãzãg±ãpjXoa>jŒ«≥û–ù≥ßÀëô£–ã∆PÅ˜@vk~el£t®™£§®Ølös˚bÉÙ¯π©œæÃ˜ JúŸÁÏ˜à˜8ô·•≥¬À©Æ∏—ãæãøÇ¢p¨s®I®RãFã-`ã&ãiïn≥ãßãñ£ãúãØeóã¶¨æßµÿ¨HOcxFycoKÖ}sFãPêï˚@£™öØ®s§lnstle´~†˚—ãû˘ûƒ˜?Ë˜t˚^Ò˜h0˜¯è˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(.˝c»ù˜ΩûAçsïŸ¯P€§í‘éû˚ΩxﬁáôA¸PDz6â˜∫ïv˘"ûê˙3˙8˘*˚Zx≠àÆádvÉmÉv˚˚Á˚˜È|≤°ãúØπç™û˚üx¿äöÖ¨8¨9 ˚Æ˚$¯ÜòÖúãô•üë∏çû˚âxƒÜôn´8±'Û˚∞æ˚-ö˜.¯;∂˚›˚fÆ#ö∆˜U€˜j–˜Nô≤õôºì”ív˜¿v˜>ö†˘5¯œ¯V|£ÜüásÖpÄr1˚r;˜j|≤Öñãù®§é¨êö˚_|¥ÜñÑ∞˚0˚[]˜P˜Æß¢è¢çö˚H|§âì~ü[˜˚ÍiôêÅíëêñßô˜˜ÑÊ˚ÄôgçÑìãìèï≤õ˜˜Óö∞êï†íö˚*˚Ωã¯à¯à˚Ω¸àY˚—˚0§˘î§„◊˜ø˘§˚g˝∆˜g§5Zã≥ó˘4ôã©∏˚—˚0§˘î§˜=◊≠˚r˜g˘∆˚gr·ºãc˝4}ãm^˚*ãö¯8ö˜Cô∑w›ﬂÿí˜~öwåjçuìã¥˜Iç˜˚LózîÇãÑ~~àÉx|˜nöpçdíXÀ˚-˜V®¶˜˜ßã¿ãö˚`}µìÉÄÇÉÄ|}ciPTglâç¯4áç¯VzV}Z~{åìîåò≤ë{^¸vUÉâHÄ”ãû˘û˜Ò¯1˘ºâûâpinp˚v˚_˜a’ôñŸêû˚∞xœÜ°Ñ=¸E9|=áx˜Æû=èõ—˜O•†ı"≠iÎ$ãluzäVâx˜≈ûRâh±J”˚}˜é˜R˜P“—†é«êû˚ö˚bÅƒ˜Üv˜<£∫˜?∞„FﬁK˜sÄ‹√˜Ü¯è˚'˜(r¢àã{ãlänâvú}óÉ˜.*˚ñ¸èÈ˜≥˜màl|ÜÇl~ufn™∫ç≠ñ√˜+Ω˜/˚^ÇÄ~Åvnã®®˜W«ãÔ˚)Â˚\Dc{óo™•û°†îÜöãö™±ù¨©∫ÄCNÈ˚7K4i'Høf¡¬¿≥¨∞Cêµäùõ™åºµ”ãû˜Y¥¯5wÃ˜?ö˘G¸6˜t˜W˜h˜¯è˜.Ïïëüòã¢èäßk}Ñãtt˚'˚(˚¥˝cË˘Vû_é}ñk‘˚ç¯Ãw˚d¸x_lBtryxzâ{äx˜Zûv\ãµñéôêòπ˜	˜ö¥+ë}òjã{fjäfx˜ì¸~˜ï˜˜ß˜˚ß”ãû˘ûï˘J˘L˘*˚Çx≠äØälxzwtn˚˚a∆HÍy¨ãü©£åøåû˚¬x≈Ü†âÒ˚*˜˚4˚1˚U<*Ä~Táx˜}ûdçfé´û™≤†•˜˜(Í˚ õtÆUãylpãYàx˜ΩûWêwôd¬˚T˜¶˜&˜J—‚•é¿è}ô˘*ô˚vï˜sã˜öì¸|å}ô¯Vï˜^ô˚nå¯sì˜ã	ß
ﬂ˜é˘
endstream
endobj
16 0 obj
<<
/FontFile3 15 0 R
/CapHeight 662
/StemH 0
/Type/FontDescriptor
/StemV 84
/XHeight 676
/FontName/KIFCEI+Times-Roman
/Ascent 683
/Flags 34
/FontBBox[-168 -218 1000 898]
/ItalicAngle 0
/Descent -217
>>
endobj
17 0 obj
<<
/LastChar 238
/Name/F0
/BaseFont/KIFCEI+Times-Roman
/FontDescriptor 16 0 R
/Subtype/Type1
/Encoding 14 0 R
/FirstChar 32
/Widths[250 0 0 0 0 833 0 0 333 333 0 0 250 333 250 278 500 500 500 500 500 500 500 500 500 500 278 278 0 0 0 444 921 722 667 667 722 611 556 722 722 333 389 722 611 889 722 722 556 0 667 556 611 722 722 944 722 722 611 333 0 333 0 500 0 444 500 444 500 444 333 500 500 278 278 500 278 778 500 500 500 500 333 389 278 500 500 722 500 500 444 0 0 0 0 0 0 0 0 0 722 0 0 444 444 0 0 0 0 0 444 0 0 0 278 0 0 0 500 500 0 0 0 0 500 0 0 0 0 400 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 0 0 0 0 0 276 0 0 0 0 444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 0 0 333 0 0 0 722]
/Type/Font
>>
endobj
18 0 obj
<<
/BaseEncoding/MacRomanEncoding
/Type/Encoding
/Differences[32/space 40/parenleft/parenright 44/comma 49/one/two 65/A 67/C/D/E/F 73/I 76/L 78/N/O/P 82/R/S/T 86/V 89/Y 97/a 105/i 108/l 115/s 117/u 132/Ntilde 146/iacute 238/Oacute]
>>
endobj
19 0 obj
<<
/Subtype/Type1C
/Length 3061
/Length1 3061
>>
stream
  EXIIHN+Times-Bold   @¯ ¯¯¯¯˚<˚n˙|˙;
 ãã
 ãã      Q¬  æ ö§©001.007Copyright (c) 1985, 1987, 1989, 1990 Adobe Systems Incorporated.  All Rights Reserved.Times is a trademark of Linotype AG and/or its subsidiaries.Times BoldTimes    & % * 5 0 3 " - 1 7 / $ ª  : ' 4 ∫ M V ” T J B 	    
    v ÷b∂/ä”FôıP”÷>¢'–˝\∫)zˇ	4	o	¢	¯
-¸$úã§r™˜æ≠˜´≠r§Û˜6˜6•˜§Øõ˘πàµâI¸xMlàRÖwr¯›≥˜do˚+L%q)Jxó∑˜ÜÓæm˚ó•˜Êq|˚Xq+å˜|∂ùè¬˜“r˚"¢§˜]¸’”ã§rÆ¯Û≠r§Ï˜6˜ï˜Blô˜–˜êì˜ ˜0˜L˜.0˜B˚¨˚≈úr≤á∑âN¸ÅfwnLl˜â¯Œ°ää§À˜@¢˚i0˚É3K˚[Çù≥˚ôã§˘§˜˜6¯§TècéÀ¯xœªå∫ç§˚Úrπà∫âI¸xMdáUÜr˜Úúã§¯ˇ´ˇ  Ä ˇ Ä ˜U˜6˜Tß¯ï§Aêsç‡¯£–áÚÜü˚4®â˜]¸Ïà˚]®ü˜4Úê—è¸£7sâBÖr˜˘˜x¨˘¨Æ˜E˜ˆ˜E¯˘&˜ ∞˚D˚&4Ö˚˚?˚?Ö˜‚˜&∞˜D˜ ¨˚U˚5˚˚n˚f˜)˚%˜a˜a˜)˜%˜f˜n˚5˜˚U”ã§˜¥´˜Ω≠r§˜˜6˜K˜?Ï˜®¯Ï™êçñ¬€¥`&˚Wu˚ä¯K˚‘|åù}˚]˜±¡úÚ™ã˜‹˜<˚hìE˚÷rƒá™â5¸N:wàGÉr˜Ê§Iîué€˜X¶˜c˚Õ˜a”ã§˜@≤¯Zwî˘<˘E§[â{≠^ˆ˚s¯¢o˚r¸∏m@}iUÉr˜_§iç[é±õõ¥ß”˜uôk´ApjyäMÜr˜ÿ¸à˜ÄÈ˜á˚áúã§r™˘ §Ù˜6p˘˜wn˚]S8˚+Huìª¯l„™å—é§˚Òr∏à¥âI∞¸xNmàSÑpr¯÷dã§˜™Æ˜√Ær§Ô˜6˜:˜@Ïõ˜‚§Fîxç‹˜N˜åæåÀØ€∏ñ“ãÆã˜=˚Jö;ã˚÷‹r¿Ü™à7¸NS}~ÇÑÜâäZÉÏ˜ä¯Ÿ°åòò≠›Øe˚˚^n˚ç”év˘1§õ˘A˘Q˘8˚irƒà®ádwÄqÇt˚˚›˚˜–Å§wµãû±¢ã è§˚‰r∂Ñöà•O˜î¸Î¶˜x¯ﬂ°√òû¬í”évù§˘§Û∑¯C∑xõ˜w§Aìvû”¯$ç∏¯Q¸≤ß¯·ªë¢”î§˚kr‹ÖójO˚√â˚Ô¯?˚gròõàF√x¸nIoÑOÑ”xª˘	¨º˜E¯6§˘%˜,.8@m=l<ö”afÀÖÎ«˜=≤˜-˜&˜ﬂ˚	4Æ§˜~prÅÇvpq>º1˚f˚$˚0˚_˚O˜˚8˜}˜Ÿ ﬁ‘˜x¨˘¨∫˜MÆ˜EÏ˜Çû˜E˜s˜f(˜∞¯¸£öõïßØlìyÅxâqt˚˚1√¸˝v‘¯˘&˜ ∞˚D˚&4Ö˚˚?˚?Ö˜‚˜&∞˜D˜ ¨˚U˚5˚˚n˚f˜)˚%˜a˜a˜)˜%˜f˜n˚5˜˚U¸$”ã§˘§˜™˜6˘O˘8˚pr∫à∞âdpkTÑÄ˚˚M˚˜|Éõ{§ãößóë–§˚„ræà£`êÇ˜K˚‡˚'8sâFÑr˜Ô§Eíuçﬁ˜L˜S˜Àü´®èûédã§˜ƒ≠˜´≠r§Û˜6˜-§˜£ﬁõ˘∫à¥âI¸xMlàRÖr˜¸§EécçÕ˜}˜õB9ñ§˜Êr};|D˚çÓ˜|∂ùè¡˜@¶L#°£˜]¸À-x¨˘™Æ®w˜˜Ö˜P©‰¯x¯o˜mmxÜÜ|tn\¨;ÿ˚Rl˚N]ã5˜?9ŒkÃl∫sãH~Ü(˚Ë˚Q˜wn˚ã®õèêù†™∏iÍ˜LÀ˜„˜?≈iú˚'‘‘7µx°¡Ã¬©ø˜
«˚Eù”évù§˘§‹˜Û∑™¯Æ∑˜W˜f•¯πùåõ®´ôããuΩ®~õÑ•Ñùã‰¢ÁÆî`zÖÅkf~ããópcùÅèkönã/x1hÑ˚G˝ãjõ˜w§Aìvû”¯$ç™¯Q¸≤ß¯·ªë¢”î§˚kr‹ÖójO˚√â˚Ô¯?˚gròõàF√j¸nIoÑOÑ¸ã£˘£Œ˜˜ì£dÅ™®¯‰˚Rsºç\Ä¸ísÄgcs˜É-}Ãl¢¯£Ã˜˜˜x¯≠∂^åÄù≤˜¸˚]s≠àßäT∏˚ØxxrreTä∂ß˜Á˚Ps¥Ñìc˚êD≠FÒŒπ¥§®Jxƒûôå˜ò¸ã£¯1£Œ˜Mø˜Ç˚q˜i0˜∞¯¸£öõïßØlìyÅxâqt˚˚1√˚ ¸§»˜ì£dèÉ°™¯˚Ts±ÑöÑ^˚∫[zàgÇs˜É˚ô}≠¯8¨§§tÔ˜Î`°‰˜Ë˜⁄˜%uÉàáyxb°\ÿ/HP3˚.˜Çëã/mvgYË˚sÙ¶Öo˚9§üïëìñîœnΩËÀ∆Íÿ˜8˚~tãÒ™ß•Ø‰ƒπ`D†¸ã£¯1£÷˜/«˜/˚&˜Ë˜ì£dèÉ°™¯˚Ts±ÑöÑ^˚∫[zàgÇs˜É0˚W¯˘`´iπ∂≠¨∑∂iÆ`^jga˚*}ÀK“¯´§˜&˚˜˜˜¨¯mÀÅÅàààäáãuãûë˜ôÈ2∂˚˚LNLG¡ãóøö±ù≤mìã†õ¢üØ’ôfXBt˚"`˚c#?…lª£—êÃÃoëìa—∏∞£¨ß˚Wƒ{}tpig|Ø™‚Ó®¢ê˚—˚'v˘Úwπ˜˜∆˘JTr˚a˚˚∏9ß˚j˜|˚ß*∆Y“˜§˜≈À∑ﬁ√˚*ã£˘,w˜N˜(¯N£(Ç¶Œ¯Œz˚ê˚qò≠≠óô≤ã_r¸Màd˚ås¯¸$Ö˜5˜/œƒ˚H¿©˜Ã˜øn…B]gmWLπ{ßóêçãêòíÅS:Rox˚*ã˜¯M˜˜¿˜¯r˜gsGoÇÅ!˚+˜6˜.˜˜ã◊ã®˜,˚ÆM˚!P˚'Rwßﬂ∞…ë¢Úõ'o˚
˚˚˚6˚At¯4˚—˚'v˘Úw˜B˜¶˚<¬§˜a˜˜∏›o˜j˚|˜oÏPΩD˚§˚≈K_8Sxû˘8ö˚zó˜†í¸ué}ô¯Vï˜^ô˚nå¯sì˜ã	˜å
7í	˜é˘
endstream
endobj
20 0 obj
<<
/FontFile3 19 0 R
/CapHeight 676
/StemH 0
/Type/FontDescriptor
/StemV 139
/XHeight 691
/FontName/EXIIHN+Times-Bold
/Ascent 676
/Flags 262178
/FontBBox[-168 -218 1000 935]
/ItalicAngle 0
/Descent -203
>>
endobj
21 0 obj
<<
/LastChar 238
/Name/F1
/BaseFont/EXIIHN+Times-Bold
/FontDescriptor 20 0 R
/Subtype/Type1
/Encoding 18 0 R
/FirstChar 32
/Widths[250 0 0 0 0 0 0 0 333 333 0 0 250 0 0 0 0 500 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 0 722 722 667 611 0 0 389 0 0 667 0 722 778 611 0 722 556 667 0 722 0 0 722 0 0 0 0 0 0 0 500 0 0 0 0 0 0 0 278 0 0 278 0 0 0 0 0 0 389 0 556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 0 0 0 0 0 0 0 0 0 0 0 0 0 278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 778]
/Type/Font
>>
endobj
22 0 obj
<<
/Kids[23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R]
/Type/Pages
/Count 6
/Parent 29 0 R
>>
endobj
23 0 obj
<<
/MediaBox[0 0 498.89801 691.65399]
/Resources<</ProcSet[/PDF/Text]/Font<</F1 21 0 R/F0 17 0 R>>/ExtGState<</GS2 3 0 R/GS1 2 0 R/GS3 4 0 R/GS0 1 0 R>>>>
/Contents 5 0 R
/Parent 22 0 R
/Type/Page
>>
endobj
24 0 obj
<<
/MediaBox[0 0 498.89801 691.65399]
/Resources<</ProcSet[/PDF/Text]/Font<</F0 17 0 R>>/ExtGState<</GS2 3 0 R/GS1 2 0 R/GS3 4 0 R/GS0 1 0 R>>>>
/Contents 6 0 R
/Parent 22 0 R
/Type/Page
>>
endobj
25 0 obj
<<
/MediaBox[0 0 498.89801 691.65399]
/Resources<</ProcSet[/PDF/Text]/Font<</F0 17 0 R>>/ExtGState<</GS2 3 0 R/GS1 2 0 R/GS3 4 0 R/GS0 1 0 R>>>>
/Contents 7 0 R
/Parent 22 0 R
/Type/Page
>>
endobj
26 0 obj
<<
/MediaBox[0 0 498.89801 691.65399]
/Resources<</ProcSet[/PDF/Text]/Font<</F0 17 0 R>>/ExtGState<</GS2 3 0 R/GS1 2 0 R/GS3 4 0 R/GS0 1 0 R>>>>
/Contents 8 0 R
/Parent 22 0 R
/Type/Page
>>
endobj
27 0 obj
<<
/MediaBox[0 0 498.89801 691.65399]
/Resources<</ProcSet[/PDF/Text]/Font<</F0 17 0 R>>/ExtGState<</GS2 3 0 R/GS1 2 0 R/GS3 4 0 R/GS0 1 0 R>>>>
/Contents 9 0 R
/Parent 22 0 R
/Type/Page
>>
endobj
28 0 obj
<<
/MediaBox[0 0 498.89801 691.65399]
/Resources<</ProcSet[/PDF/Text]/Font<</F0 17 0 R>>/ExtGState<</GS2 3 0 R/GS1 2 0 R/GS3 4 0 R/GS0 1 0 R>>>>
/Contents 10 0 R
/Parent 22 0 R
/Type/Page
>>
endobj
30 0 obj
<<
/Kids[31 0 R 32 0 R]
/Type/Pages
/Count 2
/Parent 29 0 R
>>
endobj
31 0 obj
<<
/MediaBox[0 0 498.89801 691.65399]
/Resources<</ProcSet[/PDF/Text]/Font<</F0 17 0 R>>/ExtGState<</GS2 3 0 R/GS1 2 0 R/GS3 4 0 R/GS0 1 0 R>>>>
/Contents 11 0 R
/Parent 30 0 R
/Type/Page
>>
endobj
32 0 obj
<<
/MediaBox[0 0 498.89801 691.65399]
/Resources<</ProcSet[/PDF]/ExtGState<</GS1 2 0 R/GS0 1 0 R>>>>
/Contents 12 0 R
/Parent 30 0 R
/Type/Page
>>
endobj
29 0 obj
<<
/Type/Pages
/Kids[22 0 R 30 0 R]
/Count 8
>>
endobj
33 0 obj
<<
/Type/Catalog
/PageLabels 13 0 R
/Pages 29 0 R
>>
endobj
34 0 obj
<<
/XPressPrivate(%%DocumentProcessColors: Black\n%%EndComments)
/Producer(QuarkXPress(tm) 6.5)
/CreationDate(20080721085646)
/Title<FEFF004D0061007100750065007400610063006900F3006E00200031>
/Creator(QuarkXPress(tm) 6.5)
>>
endobj
xref
0 35
0000000000 65535 f 
0000000015 00000 n 
0000000059 00000 n 
0000000111 00000 n 
0000000157 00000 n 
0000000204 00000 n 
0000008802 00000 n 
0000021462 00000 n 
0000031475 00000 n 
0000042622 00000 n 
0000052464 00000 n 
0000063014 00000 n 
0000067987 00000 n 
0000068104 00000 n 
0000068150 00000 n 
0000068700 00000 n 
0000078924 00000 n 
0000079142 00000 n 
0000079901 00000 n 
0000080152 00000 n 
0000083296 00000 n 
0000083518 00000 n 
0000084152 00000 n 
0000084259 00000 n 
0000084475 00000 n 
0000084681 00000 n 
0000084887 00000 n 
0000085093 00000 n 
0000085299 00000 n 
0000085955 00000 n 
0000085506 00000 n 
0000085585 00000 n 
0000085792 00000 n 
0000086019 00000 n 
0000086088 00000 n 
trailer
<<
/Size 35
/Root 33 0 R
/Info 34 0 R
/ID[<49DC67DC39BA5B2BF593E3ADD01C8C92><49DC67DC39BA5B2BF593E3ADD01C8C92>]
>>
startxref
86328
%%EOF
